subject: PUBCHEM.COMPOUND:45382195

subject_name: Thymosin Beta 4

object_name: epidermolysis bullosa


subject: UMLS:C0076616

subject_name: Thymosin beta-4

tested_intervention: unsure


subject: CHEBI:38940

subject_name: Sunitinib

object_name: Pelvic Cancer

tested_intervention: yes


subject: CHEBI:38940

object_name: head and neck neoplasm


subject: CHEBI:38940

object_name: head and neck cancer


subject: CHEBI:38940

object_name: nervous system neoplasm


subject: CHEBI:38940

object_name: nervous system cancer


subject: CHEBI:38940

object_name: neoplasm of thorax


subject: CHEBI:421707

subject_name: Abacavir

object_name: Acute HIV infection


subject: PUBCHEM.COMPOUND:57414794

subject_name: Dolutegravir


subject: DRUGBANK:DB06063

object_name: digestive system neuroendocrine tumor, grade 1/2


subject: DRUGBANK:DB06063

object_name: digestive system neuroendocrine neoplasm


subject: UMLS:C1314412

subject_name: INJECTION, ALEFACEPT, 0.5 MG ADMINISTERED

object_name: psoriatic arthritis


subject: UNII:ELK3V90G6C

subject_name: Alefacept


subject: CHEBI:60802

subject_name: ropivacaine

object_name: Arm Injuries


subject: CHEBI:31300

subject_name: BOSENTAN

object_name: Eisenmenger syndrome


subject: CHEBI:51450

subject_name: Bosentan


subject: CHEBI:192614

subject_name: Homosildenafil


subject: UNII:L6WO34R9YG

subject_name: N-Desmethyl sildenafil (UK-103,320)


subject: PUBCHEM.COMPOUND:131769997

subject_name: Hydromorphone 3-beta-O-glucuronide


subject: CHEBI:183660

subject_name: Acetildenafil


subject: UNII:80X7B1F6NW

subject_name: LODENAFIL


subject: CHEBI:9139

subject_name: Sildenafil


subject: CHEBI:3614

subject_name: Chlorhexidine

object_name: Emergency surgery


subject: PUBCHEM.COMPOUND:73005958

subject_name: Carfilzomib

object_name: kidney failure


subject: UMLS:C1709429


subject: CHEBI:6129

subject_name: Ketorolac

object_name: wet macular degeneration


subject: PR:000022673

subject_name: antigen 43

object_name: leukemia


subject: PR:000022673

object_name: childhood leukemia


subject: CHEBI:64103

subject_name: sodium butyrate

object_name: inflammatory bowel disease


subject: UMLS:C0142812

subject_name: Sodium Butyrate


subject: CHEBI:30772

subject_name: Butyric Acid


subject: CHEBI:231005

subject_name: 2-(Trifluoromethyl)isonicotinic acid

object_name: Advanced cancer


subject: CHEBI:63587

subject_name: Eribulin


subject: CHEBI:85994

subject_name: Lenvatinib

object_name: leiomyosarcoma


subject: CHEBI:85994

object_name: Childhood Leiomyosarcoma


subject: CHEBI:85994

object_name: Adult Leiomyosarcoma


subject: CHEBI:85994

object_name: Adult Soft Tissue Sarcoma


subject: CHEBI:85994

object_name: adult liposarcoma


subject: CHEBI:85994

object_name: liposarcoma


subject: CHEBI:85994

object_name: pediatric liposarcoma


subject: CHEBI:3504

subject_name: Cefpodoxime

object_name: urinary tract infection


subject: CHEBI:3504

object_name: bacterial urinary tract infection


subject: CHEBI:3504

object_name: Urinary Tract Infection, CTCAE


subject: CHEBI:41001

subject_name: Benzoylecgonine

object_name: disease transmission


subject: PUBCHEM.COMPOUND:251912

subject_name: Benzoyl ecgonine


subject: UMLS:C2698319

subject_name: Bacillus Calmette-Guerin Antigen


subject: UMLS:C0004886

subject_name: BCG Vaccine


subject: PR:000002994

subject_name: natural resistance-associated macrophage protein 1


subject: CHEBI:233364

subject_name: Bryostatin

object_name: Recurrent ovarian cancer


subject: CHEBI:233364

object_name: fallopian tube carcinoma


subject: CHEBI:233364

object_name: fallopian tube cancer


subject: CHEBI:233364

object_name: Stage IV Ovarian Cancer AJCC v6 and v7


subject: CHEBI:233364

object_name: Ovarian cancer stage IV


subject: CHEBI:233364

object_name: Ovarian cancer stage III


subject: CHEBI:233364

object_name: peritoneum cancer


subject: CHEBI:88353

subject_name: Bryostatin 1


subject: CHEBI:88353


subject: CHEBI:88353


subject: CHEBI:88353


subject: CHEBI:88353


subject: CHEBI:88353


subject: CHEBI:88353


subject: UMLS:C2347570

object_name: pancreatic adenocarcinoma


subject: UMLS:C2347570

object_name: Metastatic malignant neoplasm to pancreas


subject: UNII:768FW21J3L

subject_name: Famitinib

object_name: nasopharyngeal carcinoma


subject: UNII:768FW21J3L

object_name: nasopharyngeal carcinoma, susceptibility to, 1


subject: UMLS:C5555006


subject: UMLS:C5555006


subject: UNII:JSV288Q5CV

subject_name: Famtozinameran

object_name: Systemic allergic reaction


subject: PUBCHEM.COMPOUND:1805

subject_name: Azacytidine, 5-

object_name: Recurrent Childhood Brain Neoplasm


subject: CHEBI:2038

subject_name: Azacitidine


subject: CHEBI:35181

object_name: Childhood Breast Carcinoma


subject: CHEBI:35181

object_name: breast carcinoma


subject: CHEBI:35181

object_name: breast cancer


subject: CHEBI:18198

subject_name: 4-amino-4-deoxychorismic acid


subject: CHEBI:18198


subject: CHEBI:18198


subject: CHEBI:157780

subject_name: S-Cysteinosuccinic acid


subject: CHEBI:157780


subject: CHEBI:157780


subject: PR:000022058

subject_name: biodegradative arginine decarboxylase


subject: PR:000022058


subject: PR:000022058


subject: PR:000007791

subject_name: acidic amino acid decarboxylase GADL1


subject: PR:000007791


subject: PR:000007791


subject: PR:000023971

subject_name: biosynthetic arginine decarboxylase


subject: PR:000023971


subject: PR:000023971


subject: UniProtKB:Q7NSA6

subject_name: ADC_CHRVO Acetoacetate decarboxylase (sprot)


subject: UniProtKB:Q7NSA6


subject: UniProtKB:Q7NSA6


subject: PR:000032161

subject_name: antizyme inhibitor 2


subject: PR:000032161


subject: PR:000032161


subject: UniProtKB:D4A693

subject_name: AZIN2_RAT Antizyme inhibitor 2 (sprot)


subject: UniProtKB:D4A693


subject: UniProtKB:D4A693


subject: DRUGBANK:DB10516

subject_name: Casein

object_name: Muscle function outcome


subject: UMLS:C0026138

subject_name: Milk Proteins


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: UMLS:C3537249

subject_name: D Vitamin


subject: UMLS:C0074926

subject_name: Soy Proteins

object_name: Hypercholesterolemia


subject: CHEBI:42941

object_name: Advanced Hepatocellular Carcinoma


subject: UNII:7DT29059VX


subject: CHEBI:4636

subject_name: Diphenhydramine

object_name: pervasive developmental disorder


subject: CHEBI:4636

object_name: autism


subject: CHEBI:4636

object_name: autism spectrum disorder


subject: UNII:5LO1ZK1LCW

object_name: asthma


subject: CHEBI:64073

object_name: aortic valve disorder


subject: CHEBI:64073

object_name: aortic valve disease 1


subject: CHEBI:64073

object_name: Aortic Valve Disease, CTCAE


subject: CHEBI:64073

object_name: cardiogenic shock


subject: CHEBI:64073

object_name: Renal Failure, CTCAE


subject: UNII:9P1872D4OL

subject_name: Exenatide


subject: UNII:9P1872D4OL


subject: UNII:9P1872D4OL


subject: UNII:9P1872D4OL


subject: UNII:9P1872D4OL

object_name: kidney failure


subject: UNII:9P1872D4OL


subject: UNII:9P1872D4OL

object_name: stroke disorder


subject: UNII:9P1872D4OL

object_name: cerebrovascular disorder


subject: UNII:9P1872D4OL

object_name: Stroke (heart beat)


subject: UNII:9P1872D4OL

object_name: Stroke, CTCAE


subject: MESH:C000719630

object_name: alcohol abuse


subject: MESH:C000719630

object_name: alcohol dependence


subject: CHEBI:37845

subject_name: growth hormone

object_name: spinal muscular atrophy


subject: UNII:NQX9KB6PCL

subject_name: Somatotropin


subject: UNII:K4YTU42T8G

subject_name: Sebelipase alfa

object_name: cholesteryl ester storage disease


subject: UMLS:C4727019

subject_name: CD137L/Epstein-Barr Virus-Targeting Autologous Dendritic Cell Vaccine

object_name: nasopharyngeal carcinoma


subject: UMLS:C4727019

object_name: nasopharyngeal carcinoma, susceptibility to, 1


subject: UMLS:C4727019

object_name: malignant tumor of nasopharynx


subject: CHEBI:31355

subject_name: Carboplatin

object_name: extraocular retinoblastoma


subject: CHEBI:31355

object_name: pediatric extraocular retinoblastoma


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: PUBCHEM.COMPOUND:2767


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4026


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:4911


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: UNII:PVI5M0M1GW


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: PR:000005932


subject: CHEBI:9570

subject_name: Thiotepa


subject: CHEBI:9570


subject: UNII:T5IRO3534A

subject_name: Oncovin


subject: UNII:T5IRO3534A


subject: PUBCHEM.COMPOUND:3717450

subject_name: Leurocristine


subject: PUBCHEM.COMPOUND:3717450


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:28445


subject: CHEBI:63605

subject_name: Ixabepilone

object_name: carcinosarcoma of the corpus uteri


subject: CHEBI:63605

object_name: uterine carcinosarcoma


subject: CHEBI:16302

object_name: type 2 diabetes mellitus


subject: UNII:81G40H8B0T

subject_name: VITAMIN A


subject: UMLS:C3714656

subject_name: Vitamin A Drug Class


subject: CHEBI:12777

subject_name: Vitamin A


subject: UMLS:C2825076

subject_name: Vitamin A [EPC]


subject: UMLS:C1268859

subject_name: Zinc supplement


subject: CHEBI:91397

subject_name: Ibrutinib

object_name: large B-cell lymphoma


subject: UMLS:C3714803

subject_name: Vitamin E Drug Class

object_name: neurotoxicity


subject: CHEMBL.COMPOUND:CHEMBL3989727

subject_name: VITAMIN E


subject: CHEBI:18145

subject_name: Vitamin E


subject: UMLS:C1879771

subject_name: BIBF 1120

object_name: Platinum-Sensitive Disease


subject: CHEBI:85164

subject_name: Nintedanib


subject: CHEBI:27594

subject_name: Graphite

object_name: acute renal disease


subject: CHEBI:27594

object_name: acute kidney failure


subject: CHEBI:6121

subject_name: Ketamine

object_name: cocaine use disorder


subject: CHEBI:6121

object_name: cocaine dependence


subject: UMLS:C2607231

subject_name: ABT 335

object_name: coronary atherosclerosis


subject: CHEBI:52717

subject_name: Bortezomib

object_name: autoimmune encephalitis


subject: UNII:Q6C9WHR03O

subject_name: tisagenlecleucel

object_name: Mantle cell lymphoma recurrent


subject: CHEBI:63791

subject_name: Lenalidomide

object_name: metastatic prostate carcinoma


subject: UNII:6897GXD6OE

object_name: Chronic fatigue


subject: CHEBI:4875

subject_name: Etanercept

object_name: Rheumatic arthritis


subject: CHEBI:4875

object_name: rheumatic fever


subject: PR:000001959

subject_name: tumor necrosis factor receptor superfamily member 1B


subject: PR:000001959


subject: CHEBI:71200

subject_name: Tofacitinib


subject: CHEBI:71200


subject: UMLS:C2348842

object_name: cancer


subject: UMLS:C2348842

object_name: neoplasm


subject: UMLS:C2348842

object_name: adult lymphoma


subject: UMLS:C2348842

object_name: lymphoma


subject: UMLS:C2348842

object_name: pediatric lymphoma


subject: MESH:D006495

subject_name: Heparin, Low-Molecular-Weight

object_name: lung neoplasm


subject: UMLS:C3536766

subject_name: Low Molecular Weight Heparin [EPC]


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide

object_name: acute myeloid leukemia, t(16;16)(p13.1;q22)


subject: PUBCHEM.COMPOUND:596

object_name: acute myeloid leukemia, inv(16)(p13.1;q22)


subject: PUBCHEM.COMPOUND:596


subject: CHEBI:28680

subject_name: Cytarabine


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:95165


subject: CHEBI:95165


subject: CHEBI:95165


subject: CHEBI:50131

subject_name: Decitabine


subject: CHEBI:50131


subject: CHEBI:50131


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim

object_name: High Risk Myelodysplastic Syndrome


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UMLS:C3892863

subject_name: filgrastim-sndz


subject: UMLS:C3892863

object_name: De Novo Myelodysplastic Syndrome


subject: UMLS:C3892863


subject: UMLS:C3892863


subject: UMLS:C3892863

object_name: Untreated Adult Acute Myeloid Leukemia


subject: UMLS:C3892863

object_name: acute myeloid leukemia, t(8;21)(q22; q22.1)


subject: UMLS:C3892863


subject: PUBCHEM.COMPOUND:3368

subject_name: Fludara


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: CHEBI:63599


subject: UNII:8GZG754X6M

subject_name: Gemtuzumab


subject: UNII:8GZG754X6M

object_name: myelodysplastic syndrome with excess blasts


subject: UNII:8GZG754X6M


subject: UNII:8GZG754X6M


subject: UNII:8GZG754X6M


subject: UMLS:C0677800

subject_name: CMA 676


subject: UMLS:C0677800


subject: UMLS:C0677800


subject: UMLS:C0677800


subject: UMLS:C0677800


subject: PUBCHEM.COMPOUND:3685


subject: PUBCHEM.COMPOUND:3685


subject: PUBCHEM.COMPOUND:3685


subject: CHEBI:42068

subject_name: Idarubicin


subject: CHEBI:42068


subject: CHEBI:42068


subject: CHEBI:30314

subject_name: Lipoic acid

object_name: attention deficit hyperactivity disorder, inattentive type


subject: CHEBI:30314


subject: CHEBI:46217

subject_name: L-alanine residue


subject: CHEBI:46217


subject: CHEBI:158283

subject_name: Ala-Leu-Ala


subject: CHEBI:158283


subject: CHEBI:16449

subject_name: DL-Alanine


subject: CHEBI:16449


subject: CHEBI:43796

subject_name: (S)-lipoic acid


subject: CHEBI:43796


subject: CHEBI:17549

subject_name: Aminolevulinic acid


subject: CHEBI:17549


subject: CHEBI:27432

subject_name: linolenic acid


subject: CHEBI:27432


subject: CHEBI:16977

subject_name: Alanine


subject: CHEBI:16977


subject: UMLS:C1328719

subject_name: OSI 211

object_name: ovarian cancer


subject: UMLS:C1328719

object_name: ovarian neoplasm


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: uterine cancer


subject: CHEBI:3215

object_name: tumor of uterus


subject: CHEBI:3215


subject: CHEBI:3215


subject: CHEBI:3215

object_name: ovarian carcinoma


subject: CHEBI:3215

object_name: leiomyoma


subject: UMLS:C4086546

subject_name: Liposomal Bupivacaine


subject: UMLS:C4086546


subject: UMLS:C4086546


subject: UMLS:C4086546


subject: UMLS:C4086546


subject: UMLS:C4086546

object_name: uterine fibroid


subject: UMLS:C4086546


subject: CHEBI:85078

subject_name: Dapagliflozin

object_name: Rheumatic mitral stenosis


subject: CHEBI:85078

object_name: Mitral stenosis


subject: CHEBI:85078

object_name: rheumatic heart disease


subject: CHEBI:9123

subject_name: Sertraline

object_name: myocardial infarction


subject: CHEBI:9123

object_name: Myocardial Infarction, CTCAE


subject: CHEBI:9123

object_name: Myocardial Infarction by ECG Finding


subject: CHEBI:9123

object_name: angina unstable


subject: CHEBI:9123

object_name: heart disorder


subject: CHEBI:25681

subject_name: Omega-3 fatty acids


subject: UMLS:C0885057

subject_name: garlic preparation

object_name: Non-genital warts NOS


subject: CHEBI:75958

subject_name: solution


subject: UMLS:C0037633

subject_name: Solutions


subject: CHEBI:3614

subject_name: Chlorhexidine


subject: UNII:FR702N558K

subject_name: Pranlukast Hydrate

object_name: chronic rhinosinusitis


subject: CHEBI:94810

subject_name: Pranlukast


subject: UNII:QR4JN1O82Q

subject_name: PEGDARBEPOETIN BETA

object_name: anemia


subject: UNII:QR4JN1O82Q

object_name: Anemia, CTCAE


subject: UNII:QR4JN1O82Q

object_name: chronic kidney disease


subject: UNII:QR4JN1O82Q

object_name: Chronic Kidney Disease, CTCAE


subject: UNII:QR4JN1O82Q

object_name: Chronic kidney disease stage 5 on dialysis


subject: UMLS:C5421006

subject_name: Pegdarbepoetin Beta


subject: UMLS:C5421006


subject: UMLS:C5421006


subject: UMLS:C5421006


subject: UMLS:C5421006


subject: CHEBI:150712

subject_name: Hyaluronic acid

object_name: glans penis cancer


subject: CHEMBL.COMPOUND:CHEMBL5314376

subject_name: HYALURONIC ACID


subject: UNII:G8RGG88B68

subject_name: Peginterferon alfa-2b

object_name: Neck Carcinoma


subject: UNII:G8RGG88B68

object_name: head and neck neoplasm


subject: UNII:G8RGG88B68

object_name: head and neck cancer


subject: UMLS:C5979817

object_name: dry eye syndrome


subject: UNII:D8G495PL3W

subject_name: VEZOCOLMITIDE


subject: UMLS:C0056562

subject_name: crystalloid solutions

object_name: Sepsis


subject: UMLS:C0056562

object_name: Sepsis, CTCAE


subject: UMLS:C0056562

object_name: hypotension


subject: UMLS:C0056562

object_name: Hypotension, CTCAE


subject: CHEBI:166902


subject: CHEBI:166902


subject: CHEBI:166902


subject: CHEBI:166902


subject: CHEBI:9943

subject_name: Venlafaxine

object_name: Hot Flashes, CTCAE


subject: CHEBI:9943

object_name: Hot flashes


subject: CHEBI:50733

subject_name: nutraceutical

object_name: Chronic Bacterial Prostatitis


subject: CHEBI:49845

subject_name: (R)-quinacrine

object_name: Creutzfeldt Jacob disease


subject: CHEBI:49845

object_name: inherited Creutzfeldt-Jakob disease


subject: CHEBI:8711

subject_name: Quinacrine


subject: CHEBI:8711


subject: CHEBI:17026

subject_name: Progesterone

object_name: Postmenopausal symptoms


subject: UMLS:C2757070

subject_name: Progesterone [EPC]


subject: UNII:6Y5629322X

subject_name: Alvelestat

object_name: Emphysema or COPD


subject: PUBCHEM.COMPOUND:521372

subject_name: Cannabidiol

object_name: psoriatic arthritis


subject: PUBCHEM.COMPOUND:521372

object_name: Heberden node


subject: PUBCHEM.COMPOUND:521372

object_name: osteoarthritis, hand


subject: CHEBI:93775

subject_name: Amethopterin

object_name: schizophrenia


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: UNII:3VHF2ZD92J

subject_name: Romosozumab

object_name: FHA (functional hypothalamic amenorrhea)


subject: CHEBI:8228

subject_name: Pioglitazone

object_name: Carcinoma breast stage IV


subject: CHEBI:8228

object_name: hyperinsulinism


subject: CHEBI:8228

object_name: Hyperinsulinemia


subject: CHEBI:8228

object_name: Drug-induced hyperglycemia


subject: PUBCHEM.COMPOUND:131750926

subject_name: Xanthan

object_name: Dysphagia


subject: PUBCHEM.COMPOUND:131750926

object_name: Dysphagia, CTCAE


subject: PUBCHEM.COMPOUND:131750926

object_name: Oral-pharyngeal dysphagia


subject: UNII:TTV12P4NEE

subject_name: Xanthan gum


subject: UNII:TTV12P4NEE


subject: UNII:TTV12P4NEE


subject: PUBCHEM.COMPOUND:155543961

subject_name: LIRAGLUTIDE

object_name: hypogonadism


subject: UMLS:C1099192


subject: CHEBI:32133

object_name: Inflammatory Response


subject: UNII:0CLL4232KD

subject_name: SIVELESTAT SODIUM


subject: UMLS:C2699305

subject_name: Sivelestat Sodium


subject: UMLS:C0299555

subject_name: polyvalent melanoma cell vaccine

object_name: skin melanoma


subject: CHEBI:90205

subject_name: Plitidepsin

object_name: adult lymphoma


subject: CHEBI:90205

object_name: pediatric lymphoma


subject: PUBCHEM.COMPOUND:73313844

subject_name: Dehydrodidemnin B


subject: PUBCHEM.COMPOUND:73313844


subject: UMLS:C0388638

subject_name: plitidepsin


subject: UMLS:C0388638


subject: CHEBI:3160

subject_name: botulinum toxin type A

object_name: Episodic migraine


subject: UMLS:C2698849

subject_name: Polyvalent antigen-KLH conjugate vaccine

object_name: Stage IB Fallopian Tube Cancer AJCC v6 and v7


subject: UMLS:C2698849

object_name: Stage IB Fallopian Tube Cancer AJCC v8


subject: UMLS:C2698849

object_name: Stage IA Fallopian Tube Cancer AJCC v8


subject: UMLS:C2698849

object_name: Stage IA Fallopian Tube Cancer AJCC v6 and v7


subject: UMLS:C2698849

object_name: Stage IV Fallopian Tube Cancer AJCC v6 and v7


subject: UMLS:C2698849

object_name: Stage IV Fallopian Tube Cancer AJCC v8


subject: UMLS:C2698849

object_name: Stage IC Fallopian Tube Cancer AJCC v6 and v7


subject: UMLS:C2698849

object_name: Stage IC Fallopian Tube Cancer AJCC v8


subject: UMLS:C2698849

object_name: Stage IIC Fallopian Tube Cancer AJCC v6 and v7


subject: UMLS:C2698849

object_name: Stage IIA Fallopian Tube Cancer AJCC v6 and v7


subject: UMLS:C2698849

object_name: Stage IIA Fallopian Tube Cancer AJCC v8


subject: UMLS:C2698849

object_name: Stage IIB Fallopian Tube Cancer AJCC v8


subject: UMLS:C2698849

object_name: Stage IIB Fallopian Tube Cancer AJCC v6 and v7


subject: UMLS:C2698849

object_name: Stage IIIA Fallopian Tube Cancer AJCC v7


subject: UMLS:C2698849

object_name: Stage IIIA Fallopian Tube Cancer AJCC v8


subject: UMLS:C2698849

object_name: Stage IIIC Fallopian Tube Cancer AJCC v8


subject: UMLS:C2698849

object_name: Stage IIIC Fallopian Tube Cancer AJCC v7


subject: UMLS:C2698849

object_name: Stage IIIB Fallopian Tube Cancer AJCC v7


subject: UMLS:C2698849

object_name: Stage IIIB Fallopian Tube Cancer AJCC v8


subject: UMLS:C2698849

object_name: Stage IV Primary Peritoneal Cancer AJCC v8


subject: UMLS:C2698849

object_name: Stage IV Primary Peritoneal Cancer AJCC v7


subject: UMLS:C2698849

object_name: Stage IIIA Primary Peritoneal Cancer AJCC v7


subject: UMLS:C2698849

object_name: Stage IIIA Primary Peritoneal Cancer AJCC v8


subject: UMLS:C2698849

object_name: Stage IIIB Primary Peritoneal Cancer AJCC v7


subject: UMLS:C2698849

object_name: Stage IIIB Primary Peritoneal Cancer AJCC v8


subject: UMLS:C2698849

object_name: Stage IIIC Primary Peritoneal Cancer AJCC v8


subject: UMLS:C2698849

object_name: Stage IIIC Primary Peritoneal Cancer AJCC v7


subject: UMLS:C2698849

object_name: Stage IV Ovarian Cancer AJCC v6 and v7


subject: UMLS:C2698849

object_name: Stage IV Ovarian Cancer AJCC v8


subject: UMLS:C2698849

object_name: Ovarian cancer stage IV


subject: UMLS:C2698849

object_name: Stage IC Ovarian Cancer AJCC v6 and v7


subject: UMLS:C2698849

object_name: Stage IC Ovarian Cancer AJCC v8


subject: UMLS:C2698849

object_name: Stage IA Ovarian Cancer AJCC v8


subject: UMLS:C2698849

object_name: Stage IA Ovarian Cancer


subject: UMLS:C2698849

object_name: Stage IB Ovarian Cancer AJCC v6 and v7


subject: UMLS:C2698849

object_name: Stage IB Ovarian Cancer AJCC v8


subject: UMLS:C2698849

object_name: Stage IIB Ovarian Cancer AJCC v6 and v7


subject: UMLS:C2698849

object_name: Stage IIB Ovarian Cancer AJCC v8


subject: UMLS:C2698849

object_name: Stage IIA Ovarian Cancer AJCC v8


subject: UMLS:C2698849

object_name: Stage IIA Ovarian Cancer AJCC V6 and v7


subject: UMLS:C2698849

object_name: Stage IIC Ovarian Cancer AJCC v6 and v7


subject: UMLS:C2698849

object_name: Stage IIIB Ovarian Cancer AJCC v6 and v7


subject: UMLS:C2698849

object_name: Stage IIIB Ovarian Cancer AJCC v8


subject: UMLS:C2698849

object_name: Stage IIIA Ovarian Cancer AJCC v6 and v7


subject: UMLS:C2698849

object_name: Stage IIIA Ovarian Cancer AJCC v8


subject: UMLS:C2698849

object_name: Stage IIIC Ovarian Cancer AJCC v8


subject: UMLS:C2698849

object_name: Stage IIIC Ovarian Cancer


subject: UMLS:C2984517

subject_name: Saponin-based Immunoadjuvant OBI-821

object_name: Stage IB Fallopian Tube Cancer AJCC v6 and v7


subject: UMLS:C2984517

object_name: Stage IB Fallopian Tube Cancer AJCC v8


subject: UMLS:C2984517

object_name: Stage IA Fallopian Tube Cancer AJCC v8


subject: UMLS:C2984517

object_name: Stage IA Fallopian Tube Cancer AJCC v6 and v7


subject: UMLS:C2984517

object_name: Stage IV Fallopian Tube Cancer AJCC v6 and v7


subject: UMLS:C2984517

object_name: Stage IV Fallopian Tube Cancer AJCC v8


subject: UMLS:C2984517

object_name: Stage IC Fallopian Tube Cancer AJCC v6 and v7


subject: UMLS:C2984517

object_name: Stage IC Fallopian Tube Cancer AJCC v8


subject: UMLS:C2984517

object_name: Stage IIC Fallopian Tube Cancer AJCC v6 and v7


subject: UMLS:C2984517

object_name: Stage IIA Fallopian Tube Cancer AJCC v6 and v7


subject: UMLS:C2984517

object_name: Stage IIA Fallopian Tube Cancer AJCC v8


subject: UMLS:C2984517

object_name: Stage IIB Fallopian Tube Cancer AJCC v8


subject: UMLS:C2984517

object_name: Stage IIB Fallopian Tube Cancer AJCC v6 and v7


subject: UMLS:C2984517

object_name: Stage IIIA Fallopian Tube Cancer AJCC v7


subject: UMLS:C2984517

object_name: Stage IIIA Fallopian Tube Cancer AJCC v8


subject: UMLS:C2984517

object_name: Stage IIIC Fallopian Tube Cancer AJCC v8


subject: UMLS:C2984517

object_name: Stage IIIC Fallopian Tube Cancer AJCC v7


subject: UMLS:C2984517

object_name: Stage IIIB Fallopian Tube Cancer AJCC v7


subject: UMLS:C2984517

object_name: Stage IIIB Fallopian Tube Cancer AJCC v8


subject: UMLS:C2984517

object_name: Stage IV Primary Peritoneal Cancer AJCC v8


subject: UMLS:C2984517

object_name: Stage IV Primary Peritoneal Cancer AJCC v7


subject: UMLS:C2984517

object_name: Stage IIIA Primary Peritoneal Cancer AJCC v7


subject: UMLS:C2984517

object_name: Stage IIIA Primary Peritoneal Cancer AJCC v8


subject: UMLS:C2984517

object_name: Stage IIIB Primary Peritoneal Cancer AJCC v7


subject: UMLS:C2984517

object_name: Stage IIIB Primary Peritoneal Cancer AJCC v8


subject: UMLS:C2984517

object_name: Stage IIIC Primary Peritoneal Cancer AJCC v8


subject: UMLS:C2984517

object_name: Stage IIIC Primary Peritoneal Cancer AJCC v7


subject: UMLS:C2984517

object_name: Stage IV Ovarian Cancer AJCC v6 and v7


subject: UMLS:C2984517

object_name: Stage IV Ovarian Cancer AJCC v8


subject: UMLS:C2984517

object_name: Ovarian cancer stage IV


subject: UMLS:C2984517

object_name: Stage IC Ovarian Cancer AJCC v6 and v7


subject: UMLS:C2984517

object_name: Stage IC Ovarian Cancer AJCC v8


subject: UMLS:C2984517

object_name: Stage IA Ovarian Cancer AJCC v8


subject: UMLS:C2984517

object_name: Stage IA Ovarian Cancer


subject: UMLS:C2984517

object_name: Stage IB Ovarian Cancer AJCC v6 and v7


subject: UMLS:C2984517

object_name: Stage IB Ovarian Cancer AJCC v8


subject: UMLS:C2984517

object_name: Stage IIB Ovarian Cancer AJCC v6 and v7


subject: UMLS:C2984517

object_name: Stage IIB Ovarian Cancer AJCC v8


subject: UMLS:C2984517

object_name: Stage IIA Ovarian Cancer AJCC v8


subject: UMLS:C2984517

object_name: Stage IIA Ovarian Cancer AJCC V6 and v7


subject: UMLS:C2984517

object_name: Stage IIC Ovarian Cancer AJCC v6 and v7


subject: UMLS:C2984517

object_name: Stage IIIB Ovarian Cancer AJCC v6 and v7


subject: UMLS:C2984517

object_name: Stage IIIB Ovarian Cancer AJCC v8


subject: UMLS:C2984517

object_name: Stage IIIA Ovarian Cancer AJCC v6 and v7


subject: UMLS:C2984517

object_name: Stage IIIA Ovarian Cancer AJCC v8


subject: UMLS:C2984517

object_name: Stage IIIC Ovarian Cancer AJCC v8


subject: UMLS:C2984517

object_name: Stage IIIC Ovarian Cancer


subject: CHEBI:83527

subject_name: Desvenlafaxine

object_name: opiate dependence


subject: UMLS:C1440867

subject_name: lactoferrin, bovine

object_name: Prematurity of fetus


subject: UMLS:C1440867

object_name: Premature infant


subject: UMLS:C1440867

object_name: Light for dates


subject: UMLS:C1440867

object_name: newborn morbidity


subject: UNII:92T1Y5X038

subject_name: Florilglutamic acid F-18

object_name: Graft Rejection


subject: UMLS:C4053691


subject: UMLS:C5139812


subject: CHEBI:93776

subject_name: Pevonedistat

object_name: adult acute myeloid leukemia


subject: CHEBI:93776

object_name: childhood acute myeloid leukemia


subject: UMLS:C5959293

subject_name: SIRP-alpha-Fc Fusion Protein HCB101

object_name: head and neck squamous cell carcinoma


subject: UNII:5S371K6132

subject_name: Rivoceranib

object_name: squamous cell lung carcinoma


subject: CHEBI:59902

subject_name: ENTECAVIR

object_name: Reactivation of hepatitis B viral hepatitis


subject: CHEBI:59902

object_name: Hepatitis B Reactivation, CTCAE


subject: CHEBI:59902

object_name: Exposure to Hepatitis B virus


subject: CHEBI:59902

object_name: rheumatoid arthritis


subject: CHEBI:473990

subject_name: Entecavir


subject: CHEBI:473990


subject: CHEBI:473990


subject: CHEBI:473990


subject: CHEBI:9130

subject_name: Sevoflurane

object_name: inhalation; vapor


subject: CHEBI:9130

object_name: Coughing on induction


subject: UNII:F94T42GL80

object_name: heart failure


subject: UNII:F94T42GL80

object_name: Heart Failure, CTCAE


subject: UNII:F94T42GL80

object_name: Cardiomegaly


subject: UNII:F94T42GL80

object_name: myocardial infarction


subject: UNII:F94T42GL80

object_name: Myocardial Infarction, CTCAE


subject: UNII:F94T42GL80

object_name: Myocardial Infarction by ECG Finding


subject: UMLS:C0770694

subject_name: trivalent influenza vaccine

object_name: Acute respiratory infections


subject: MESH:D007252

subject_name: Influenza Vaccines


subject: UMLS:C5395271

subject_name: Vaccine product containing only Influenza virus antigen (medicinal product)


subject: UNII:4B115V09LB

subject_name: Rivipansel

object_name: kidney failure


subject: CHEBI:51799

subject_name: Imipenem

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:51799

object_name: obesity


subject: CHEBI:51799

object_name: Obesity, CTCAE


subject: CHEBI:190509


subject: CHEBI:190509


subject: CHEBI:190509


subject: CHEBI:91950


subject: CHEBI:91950


subject: CHEBI:91950


subject: CHEBI:91950

object_name: Critical Illness


subject: CHEBI:3697

subject_name: Cilastatin


subject: CHEBI:3697


subject: CHEBI:3697


subject: CHEBI:3697


subject: CHEBI:4911

subject_name: Etoposide

object_name: Platinum-Resistant Ovarian Carcinoma


subject: GTOPDB:13792

subject_name: iparomlimab


subject: UNII:FN3VWV28BC

subject_name: IPAROMLIMAB


subject: UMLS:C5669553

subject_name: Iparomlimab


subject: GTOPDB:13793

subject_name: tuvonralimab


subject: UNII:8XWO7LI4LO

subject_name: TUVONRALIMAB


subject: UMLS:C5784793

subject_name: Tuvonralimab


subject: UMLS:C5206815


subject: CHEMBL.COMPOUND:CHEMBL4297562

object_name: prostate carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4297562

object_name: prostate cancer


subject: UMLS:C3274547

subject_name: Sirexatamab


subject: UMLS:C3274547


subject: CHEBI:231614

subject_name: Nivolumab

object_name: Resectable Soft Tissue Sarcoma


subject: CHEBI:231614

object_name: fibrosarcoma


subject: CHEBI:231614

object_name: Stage I Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8


subject: CHEBI:231614

object_name: Stage IA Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8


subject: CHEBI:231614

object_name: Stage IB Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8


subject: CHEBI:231614

object_name: Stage II Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8


subject: CHEBI:231614

object_name: Stage III Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8


subject: CHEBI:231614

object_name: Stage IIIA Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8


subject: CHEBI:231614

object_name: Stage IIIB Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8


subject: CHEBI:231614

object_name: spindle cell sarcoma


subject: CHEBI:231614

object_name: myxofibrosarcoma


subject: CHEBI:231614

object_name: malignant giant cell tumor of soft parts


subject: CHEBI:231614

object_name: Undifferentiated spindle cell sarcoma


subject: CHEBI:231614

object_name: Stage IA Retroperitoneal Sarcoma AJCC v8


subject: CHEBI:231614

object_name: Stage II Retroperitoneal Sarcoma AJCC v8


subject: CHEBI:231614

object_name: Stage IB Retroperitoneal Sarcoma AJCC v8


subject: CHEBI:231614

object_name: Stage III Retroperitoneal Sarcoma AJCC v8


subject: CHEBI:231614

object_name: Stage IIIB Retroperitoneal Sarcoma AJCC v8


subject: CHEBI:231614

object_name: Stage IIIA Retroperitoneal Sarcoma AJCC v8


subject: CHEBI:231614

object_name: undifferentiated pleomorphic sarcoma, inflammatory variant


subject: CHEBI:231614

object_name: childhood pleomorphic rhabdomyosarcoma


subject: CHEBI:231614

object_name: pleomorphic rhabdomyosarcoma


subject: CHEBI:231614

object_name: adult pleomorphic rhabdomyosarcoma


subject: UMLS:C2346820

object_name: Resectable Soft Tissue Sarcoma


subject: UMLS:C2346820

object_name: fibrosarcoma


subject: UMLS:C2346820

object_name: Childhood Synovial Sarcoma


subject: UMLS:C2346820

object_name: Adult Synovial Sarcoma


subject: UMLS:C2346820

object_name: synovial sarcoma


subject: UMLS:C2346820

object_name: Stage I Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8


subject: UMLS:C2346820

object_name: Stage IA Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8


subject: UMLS:C2346820

object_name: Stage IB Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8


subject: UMLS:C2346820

object_name: Stage II Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8


subject: UMLS:C2346820

object_name: Stage III Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8


subject: UMLS:C2346820

object_name: Stage IIIA Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8


subject: UMLS:C2346820

object_name: Stage IIIB Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8


subject: UMLS:C2346820

object_name: spindle cell sarcoma


subject: UMLS:C2346820

object_name: myxofibrosarcoma


subject: UMLS:C2346820

object_name: malignant giant cell tumor of soft parts


subject: UMLS:C2346820

object_name: Undifferentiated spindle cell sarcoma


subject: UMLS:C2346820

object_name: Stage IA Retroperitoneal Sarcoma AJCC v8


subject: UMLS:C2346820

object_name: Stage II Retroperitoneal Sarcoma AJCC v8


subject: UMLS:C2346820

object_name: Stage IB Retroperitoneal Sarcoma AJCC v8


subject: UMLS:C2346820

object_name: Stage III Retroperitoneal Sarcoma AJCC v8


subject: UMLS:C2346820

object_name: Stage IIIB Retroperitoneal Sarcoma AJCC v8


subject: UMLS:C2346820

object_name: Stage IIIA Retroperitoneal Sarcoma AJCC v8


subject: UMLS:C2346820

object_name: undifferentiated pleomorphic sarcoma, inflammatory variant


subject: UMLS:C2346820

object_name: childhood pleomorphic rhabdomyosarcoma


subject: UMLS:C2346820

object_name: pleomorphic rhabdomyosarcoma


subject: UMLS:C2346820

object_name: adult pleomorphic rhabdomyosarcoma


subject: CHEBI:90227

subject_name: Selumetinib

object_name: colon carcinoma


subject: CHEBI:90227

object_name: colon cancer


subject: CHEBI:90227

object_name: renal carcinoma


subject: CHEBI:90227

object_name: kidney neoplasm


subject: CHEBI:90227

object_name: kidney cancer


subject: CHEBI:90227

object_name: breast neoplasm


subject: CHEBI:90227

object_name: Colon Neoplasm


subject: CHEBI:4305

subject_name: dacarbazine

object_name: lung cancer


subject: CHEBI:4305

object_name: lung neoplasm


subject: CHEBI:4305

object_name: lung carcinoma


subject: CHEBI:4305


subject: CHEBI:4305

object_name: colorectal cancer


subject: CHEBI:4305


subject: CHEBI:4305


subject: CHEBI:4305


subject: CHEBI:4305


subject: CHEBI:4305

object_name: Childhood Breast Carcinoma


subject: CHEBI:4305

object_name: breast carcinoma


subject: CHEBI:4305

object_name: breast cancer


subject: CHEBI:4305


subject: CHEBI:4305


subject: CHEBI:4672

subject_name: Docetaxel


subject: CHEBI:4672


subject: CHEBI:4672


subject: CHEBI:4672


subject: CHEBI:4672


subject: CHEBI:114785

subject_name: Erlotinib


subject: CHEBI:114785


subject: CHEBI:114785


subject: CHEBI:114785


subject: CHEBI:79699

subject_name: Temsirolimus


subject: CHEBI:79699


subject: CHEBI:79699


subject: CHEBI:79699


subject: CHEBI:79699


subject: CHEBI:79699


subject: CHEBI:79699


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside

object_name: Gastroesophageal junction cancer


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: GTOPDB:12962

subject_name: sotatercept

object_name: Diamond-Blackfan anemia


subject: CHEMBL.COMPOUND:CHEMBL1743073

subject_name: SOTATERCEPT


subject: UMLS:C2699571


subject: CHEBI:135918

subject_name: Tucidinostat

object_name: Childhood Non-Hodgkin Lymphoma


subject: CHEBI:567361

subject_name: Cladribine

object_name: lymphoma, non-Hodgkin, familial


subject: CHEBI:567361

object_name: non-Hodgkin lymphoma


subject: CHEBI:567361

object_name: Adult Non-Hodgkin Lymphoma


subject: CHEBI:567361


subject: CHEBI:567361

object_name: Hodgkin Disease


subject: CHEBI:567361

object_name: Adult Hodgkin Lymphoma


subject: CHEBI:567361

object_name: Childhood Hodgkin Lymphoma


subject: CHEBI:27732

subject_name: Caffeine

object_name: cocaine dependence


subject: UNII:37CQ2C7X93

subject_name: Canakinumab

object_name: Periodic fever


subject: UMLS:C2718754

subject_name: Ilaris


subject: CHEBI:94518

subject_name: Tranexamic acid

object_name: obesity due to congenital leptin deficiency


subject: CHEBI:94518

object_name: obesity due to leptin receptor gene deficiency


subject: CHEBI:94518

object_name: morbid obesity


subject: CHEBI:109549

subject_name: Ramelteon

object_name: Delirium in old age


subject: CHEBI:68579

subject_name: Rivaroxaban

object_name: cardiac; prosthesis, heart, functional disturbance as result


subject: UNII:YI437801BE

subject_name: Mogamulizumab

object_name: liver carcinoma


subject: UNII:YI437801BE

object_name: Klatskin Tumor


subject: UMLS:C1831941


subject: UMLS:C1831941


subject: UMLS:C3827032

subject_name: Catequentinib Hydrochloride

object_name: breast neoplasm


subject: UNII:DZ02S3A31N

object_name: age-related macular degeneration


subject: CHEBI:233364

subject_name: Bryostatin

object_name: ovarian cancer


subject: CHEBI:233364

object_name: ovarian neoplasm


subject: CHEBI:233364

object_name: ovarian carcinoma


subject: CHEBI:88353

subject_name: Bryostatin 1


subject: CHEBI:88353


subject: CHEBI:88353


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus

object_name: Erdheim-Chester disease


subject: PUBCHEM.COMPOUND:70789204

object_name: familial atrioventricular septal defect


subject: PUBCHEM.COMPOUND:70789204

object_name: split hand-foot malformation 1


subject: CHEBI:8378

subject_name: Prednisolone


subject: CHEBI:8378


subject: CHEBI:8378


subject: PUBCHEM.COMPOUND:155543961

subject_name: LIRAGLUTIDE

object_name: bipolar disorder


subject: UMLS:C1099192


subject: CHEBI:135779

subject_name: Amrubicin

object_name: lung cancer


subject: CHEBI:135779

object_name: lung neoplasm


subject: CHEBI:135779

object_name: lung carcinoma


subject: PUBCHEM.COMPOUND:1971

subject_name: ent-Abacavir

object_name: Kaposi Sarcoma


subject: CHEBI:421707

subject_name: Abacavir


subject: CHEBI:17026

subject_name: Progesterone

object_name: congenital heart disease


subject: CHEBI:17026

object_name: Antenatal prevention of fetal injury of brain


subject: CHEBI:17026

object_name: periventricular leukomalacia


subject: UMLS:C2757070

subject_name: Progesterone [EPC]


subject: UMLS:C2757070


subject: UMLS:C2757070


subject: CHEBI:28918

subject_name: Epinephrine

object_name: Pathologic vasoconstriction


subject: CHEBI:28918

object_name: Vasoconstriction


subject: CHEBI:28918

object_name: Dental and gingival conditions


subject: CHEBI:28918

object_name: Oral soft tissue conditions


subject: UNII:8375F9S90C

subject_name: Pamiparib

object_name: Small cell lung cancer limited stage


subject: UMLS:C5446895

subject_name: Anti-CTLA-4 Monoclonal Antibody IBI310

object_name: colorectal cancer


subject: UMLS:C5446895

object_name: colorectal carcinoma


subject: UMLS:C5446895

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:35341

subject_name: steroid

object_name: opioid use


subject: CHEBI:35341

object_name: Ambulatory Status - Mastectomy


subject: CHEBI:35341

object_name: Childhood Breast Carcinoma


subject: CHEBI:35341

object_name: breast carcinoma


subject: CHEBI:35341

object_name: breast cancer


subject: UMLS:C5782153

subject_name: Steroid [EPC]


subject: UMLS:C5782153


subject: UMLS:C5782153


subject: UMLS:C5782153


subject: UMLS:C5782153


subject: PR:000022283

subject_name: excinuclease cho

object_name: Effects of high altitude


subject: UniProtKB:P76213

subject_name: CHO_ECOLI Excinuclease cho (sprot)


subject: CHEBI:50342

subject_name: L-proline residue


subject: CHEBI:17203

subject_name: Proline


subject: CHEBI:30687

subject_name: osmium atom

object_name: liver cirrhosis


subject: CHEBI:4466

subject_name: Dexmedetomidine


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: CHEBI:9144

subject_name: Silibinin

object_name: metastatic colorectal cancer


subject: CHEBI:125451

subject_name: silymarin


subject: MESH:C000728347

object_name: Overweight and obesity


subject: MESH:C000728347

object_name: Dysglycemia


subject: UMLS:C5828997


subject: UMLS:C5828997


subject: UMLS:C2744441

object_name: ovarian cancer


subject: UMLS:C2744441

object_name: ovarian neoplasm


subject: UMLS:C2744441

object_name: ovarian carcinoma


subject: UNII:6QVL057INT

subject_name: Cemiplimab

object_name: Recurrent Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma


subject: UNII:6QVL057INT

object_name: primary cutaneous peripheral T-cell lymphoma not otherwise specified


subject: UNII:6QVL057INT

object_name: peripheral T-cell lymphoma, not otherwise specified


subject: UNII:6QVL057INT

object_name: Adult Anaplastic Large Cell Lymphoma


subject: UNII:6QVL057INT

object_name: Childhood Anaplastic Large Cell Lymphoma


subject: UNII:6QVL057INT

object_name: anaplastic large cell lymphoma


subject: UMLS:C4053601


subject: UMLS:C4053601


subject: UMLS:C4053601


subject: UMLS:C4053601


subject: UMLS:C4053601


subject: UMLS:C4053601


subject: CHEBI:231679

subject_name: ipilimumab


subject: CHEBI:231679


subject: CHEBI:231679

object_name: mycosis fungoides


subject: UNII:4XE5NDT4K1

subject_name: sodium-iodide symporter


subject: UNII:4XE5NDT4K1


subject: UNII:4XE5NDT4K1


subject: UNII:4XE5NDT4K1


subject: UNII:4XE5NDT4K1


subject: UNII:4XE5NDT4K1


subject: UNII:4XE5NDT4K1


subject: PR:000015171

subject_name: sodium/iodide cotransporter


subject: PR:000015171


subject: PR:000015171


subject: PR:000015171


subject: PR:000015171


subject: PR:000015171


subject: PR:000015171


subject: UMLS:C0142963


subject: UMLS:C0142963


subject: UMLS:C0142963


subject: UMLS:C0142963


subject: UMLS:C0142963


subject: UMLS:C0142963


subject: UMLS:C0142963


subject: UMLS:C4087030

object_name: West syndrome


subject: UMLS:C4087030

object_name: Infantile Spasm


subject: UMLS:C1134664

object_name: B-cell chronic lymphocytic leukemia


subject: GTOPDB:13791

subject_name: sacituzumab tirumotecan

object_name: prostate adenocarcinoma


subject: GTOPDB:13791

object_name: Metastatic castration-resistant prostate cancer


subject: GTOPDB:13791

object_name: Prostate Adenocarcinoma with Neuroendocrine Differentiation


subject: UNII:3DV5TD1VL3

subject_name: SACITUZUMAB TIRUMOTECAN


subject: UNII:3DV5TD1VL3


subject: UNII:3DV5TD1VL3


subject: UMLS:C5237963

subject_name: ADC SKB264


subject: UMLS:C5237963


subject: UMLS:C5237963


subject: GTOPDB:13795

subject_name: tagitanlimab


subject: GTOPDB:13795


subject: GTOPDB:13795


subject: UNII:GUY458P83P

subject_name: TAGITANLIMAB


subject: UNII:GUY458P83P


subject: UNII:GUY458P83P


subject: UMLS:C0254503


subject: UMLS:C0254503


subject: UMLS:C0254503


subject: CHEBI:4445

subject_name: Desflurane

object_name: supratentorial cancer


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: liver carcinoma


subject: UMLS:C1831883

object_name: prostate carcinoma


subject: UMLS:C1831883

object_name: prostate cancer


subject: UMLS:C1831883

object_name: digestive system cancer


subject: UMLS:C1831883

object_name: female reproductive system neoplasm


subject: UNII:3HP012Q0FH

object_name: wet macular degeneration


subject: UNII:2H1PA8H1EN

subject_name: Pegaptanib


subject: CHEBI:8382

subject_name: Prednisone

object_name: myocardial ischemia


subject: CHEBI:8382

object_name: Family history of ischemic heart disease


subject: CHEBI:8382

object_name: coronary artery disorder


subject: CHEBI:8382

object_name: coronary atherosclerosis


subject: UMLS:C0769132

subject_name: Phlogenzym

object_name: Thrombophlebitis leg


subject: CHEBI:136044

subject_name: Fimasartan


subject: CHEBI:136044


subject: CHEBI:7852

subject_name: Oxycodone

object_name: Critical Illness


subject: PUBCHEM.COMPOUND:22023730

subject_name: Ganaxolone

object_name: epilepsy


subject: UMLS:C0795657

subject_name: Aralast

object_name: acute myocardial infarction


subject: UMLS:C0795657

object_name: Acute Myocardial Infarction by ECG Finding


subject: UMLS:C0002191

subject_name: alpha 1-antitrypsin


subject: UMLS:C0002191


subject: UMLS:C3540798

subject_name: Food allergenic extracts

object_name: Growth & development aspects


subject: UMLS:C3827168

object_name: myeloid leukemia


subject: CHEBI:145374

subject_name: Enasidenib


subject: CHEBI:90227

subject_name: Selumetinib

object_name: endometrium adenocarcinoma


subject: CHEBI:90227

object_name: endometrial clear cell adenocarcinoma


subject: CHEBI:90227

object_name: endometrial adenosquamous carcinoma


subject: PUBCHEM.COMPOUND:166625217

subject_name: MOTIXAFORTIDE

object_name: plasma cell myeloma


subject: UMLS:C0982332

subject_name: acellular pertussis vaccine, inactivated

object_name: hepatitis B


subject: UMLS:C0062527

subject_name: Engerix-B

object_name: pertussis


subject: UMLS:C0062527

object_name: poliomyelitis


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: intracranial meningioma


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus


subject: PUBCHEM.COMPOUND:70789204

object_name: meningioma


subject: UNII:6GNT3Y5LMF

subject_name: LEVOFLOXACIN

object_name: prostate carcinoma


subject: UNII:6GNT3Y5LMF

object_name: prostate cancer


subject: CHEBI:63598

subject_name: Levofloxacin


subject: CHEBI:63598


subject: CHEBI:8461

subject_name: Promethazine

object_name: Gastroparesis due to diabetes mellitus


subject: UMLS:C1971343

subject_name: Injection, ranibizumab, 0.1 mg administered

object_name: Polypoidal choroidal vasculopathy


subject: UMLS:C5238974

object_name: Advanced cancer


subject: PR:000004266

subject_name: AT-rich interactive domain-containing protein 3B

object_name: Chronic obstructive pulmonary disease of horses


subject: CHEBI:191205

subject_name: Phe-Phe


subject: UNII:4H9X9HO87K

object_name: Hypercholesterolemia


subject: UMLS:C1704263

subject_name: green tea extract

object_name: hepatitis C


subject: UMLS:C1704263

object_name: chronic hepatitis C virus infection


subject: UMLS:C1704263

object_name: Increased reactive oxygen species production


subject: DRUGBANK:DB14307

subject_name: Green tea leaf


subject: DRUGBANK:DB14307


subject: DRUGBANK:DB14307


subject: CHEBI:4806

subject_name: Epigallocatechin gallate


subject: CHEBI:4806


subject: CHEBI:4806


subject: CHEBI:139072

object_name: Moderate depression


subject: CHEBI:139072

object_name: Mild depression


subject: CHEBI:8614

subject_name: Psilocybin


subject: CHEBI:8614


subject: CHEBI:135089

subject_name: Propacetamol

object_name: post operative nausea and vomiting


subject: CHEBI:9168

subject_name: Sirolimus

object_name: lymphoid leukemia


subject: CHEBI:9907

subject_name: ursodiol

object_name: Pregnant


subject: UNII:4RA0KN46E0

subject_name: Upadacitinib

object_name: Dermatitis of eyelid


subject: UMLS:C2744652

object_name: Skin structures and soft tissue infections


subject: PUBCHEM.COMPOUND:6427057

subject_name: ivermectin

object_name: alcohol abuse


subject: PUBCHEM.COMPOUND:6427057

object_name: alcohol dependence


subject: CHEBI:6078

subject_name: Ivermectin


subject: CHEBI:6078


subject: DRUGBANK:DB16461

object_name: familial cold autoinflammatory syndrome


subject: CHEBI:36219

subject_name: lactose

object_name: lactose intolerance


subject: CHEBI:36218

subject_name: beta-lactose


subject: UMLS:C1260222

subject_name: Saccharum lactis, Homeopathic preparation


subject: UMLS:C1696723

subject_name: lactose - non-drug agent


subject: UMLS:C2740325

subject_name: Xiaflex

object_name: frozen shoulder


subject: UMLS:C2740325

object_name: bursitis


subject: UMLS:C2740325

object_name: Adhesive Capsulitis


subject: UNII:1WPE73O1WV

subject_name: PRALSETINIB

object_name: thyroid gland papillary carcinoma


subject: UNII:1WPE73O1WV

object_name: thyroid tumor


subject: UNII:1WPE73O1WV

object_name: thyroid cancer


subject: UNII:1WPE73O1WV

object_name: thyroid disease


subject: UNII:1WPE73O1WV

object_name: Colon Neoplasm


subject: UNII:1WPE73O1WV

object_name: intestinal cancer


subject: UNII:1WPE73O1WV

object_name: intestinal neoplasm


subject: UNII:1WPE73O1WV

object_name: digestive system neoplasm


subject: UNII:1WPE73O1WV

object_name: Neoplasm of the gastrointestinal tract


subject: UNII:1WPE73O1WV

object_name: bronchial neoplasm


subject: UNII:1WPE73O1WV

object_name: Epithelioma


subject: UNII:1WPE73O1WV

object_name: colorectal neoplasm


subject: UNII:1WPE73O1WV

object_name: endocrine gland neoplasm


subject: UNII:1WPE73O1WV

object_name: neuroendocrine neoplasm


subject: UNII:1WPE73O1WV

object_name: primitive neuroectodermal tumor


subject: UNII:1WPE73O1WV

object_name: peripheral primitive neuroectodermal tumor


subject: UNII:1WPE73O1WV

object_name: digestive system disorder


subject: UNII:1WPE73O1WV

object_name: papillary adenocarcinoma


subject: UNII:1WPE73O1WV

object_name: gastrointestinal disease


subject: UNII:1WPE73O1WV

object_name: endocrine system disorder


subject: UNII:1WPE73O1WV

object_name: neuroendocrine carcinoma


subject: UNII:1WPE73O1WV

object_name: intestinal disorder


subject: UNII:1WPE73O1WV

object_name: colonic disease


subject: CHEMBL.COMPOUND:CHEMBL4582651

subject_name: Pralsetinib

object_name: thyroid gland papillary carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4582651

object_name: thyroid tumor


subject: CHEMBL.COMPOUND:CHEMBL4582651

object_name: thyroid cancer


subject: CHEMBL.COMPOUND:CHEMBL4582651

object_name: thyroid disease


subject: CHEMBL.COMPOUND:CHEMBL4582651

object_name: Colon Neoplasm


subject: CHEMBL.COMPOUND:CHEMBL4582651

object_name: intestinal cancer


subject: CHEMBL.COMPOUND:CHEMBL4582651

object_name: intestinal neoplasm


subject: CHEMBL.COMPOUND:CHEMBL4582651

object_name: digestive system neoplasm


subject: CHEMBL.COMPOUND:CHEMBL4582651

object_name: Neoplasm of the gastrointestinal tract


subject: CHEMBL.COMPOUND:CHEMBL4582651

object_name: bronchial neoplasm


subject: CHEMBL.COMPOUND:CHEMBL4582651

object_name: Epithelioma


subject: CHEMBL.COMPOUND:CHEMBL4582651

object_name: colorectal neoplasm


subject: CHEMBL.COMPOUND:CHEMBL4582651

object_name: endocrine gland neoplasm


subject: CHEMBL.COMPOUND:CHEMBL4582651

object_name: neuroendocrine neoplasm


subject: CHEMBL.COMPOUND:CHEMBL4582651

object_name: primitive neuroectodermal tumor


subject: CHEMBL.COMPOUND:CHEMBL4582651

object_name: peripheral primitive neuroectodermal tumor


subject: CHEMBL.COMPOUND:CHEMBL4582651

object_name: digestive system disorder


subject: CHEMBL.COMPOUND:CHEMBL4582651

object_name: papillary adenocarcinoma


subject: CHEMBL.COMPOUND:CHEMBL4582651

object_name: gastrointestinal disease


subject: CHEMBL.COMPOUND:CHEMBL4582651

object_name: endocrine system disorder


subject: CHEMBL.COMPOUND:CHEMBL4582651

object_name: neuroendocrine carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4582651

object_name: intestinal disorder


subject: CHEMBL.COMPOUND:CHEMBL4582651

object_name: colonic disease


subject: UMLS:C4331210

object_name: medullary thyroid gland carcinoma


subject: UMLS:C4331210

object_name: neoplasm


subject: UMLS:C4331210

object_name: thyroid gland papillary carcinoma


subject: UMLS:C4331210

object_name: thyroid tumor


subject: UMLS:C4331210

object_name: thyroid cancer


subject: UMLS:C4331210

object_name: lung cancer


subject: UMLS:C4331210

object_name: lung neoplasm


subject: UMLS:C4331210

object_name: non-small cell lung carcinoma


subject: UMLS:C4331210

object_name: thyroid disease


subject: UMLS:C4331210

object_name: head and neck neoplasm


subject: UMLS:C4331210

object_name: germ cell tumor


subject: UMLS:C4331210

object_name: cancer


subject: UMLS:C4331210

object_name: Colon Neoplasm


subject: UMLS:C4331210

object_name: intestinal cancer


subject: UMLS:C4331210

object_name: intestinal neoplasm


subject: UMLS:C4331210

object_name: neoplasm of thorax


subject: UMLS:C4331210

object_name: digestive system neoplasm


subject: UMLS:C4331210

object_name: Neoplasm of the gastrointestinal tract


subject: UMLS:C4331210

object_name: bronchial neoplasm


subject: UMLS:C4331210

object_name: Epithelioma


subject: UMLS:C4331210

object_name: colorectal neoplasm


subject: UMLS:C4331210

object_name: endocrine gland neoplasm


subject: UMLS:C4331210

object_name: neuroendocrine neoplasm


subject: UMLS:C4331210

object_name: primitive neuroectodermal tumor


subject: UMLS:C4331210

object_name: peripheral primitive neuroectodermal tumor


subject: UMLS:C4331210

object_name: nervous system cancer


subject: UMLS:C4331210

object_name: respiratory tract neoplasm


subject: UMLS:C4331210

object_name: Neoplasms by Histologic Type


subject: UMLS:C4331210

object_name: digestive system disorder


subject: UMLS:C4331210

object_name: papillary adenocarcinoma


subject: UMLS:C4331210

object_name: respiratory system disorder


subject: UMLS:C4331210

object_name: gastrointestinal disease


subject: UMLS:C4331210

object_name: endocrine system disorder


subject: UMLS:C4331210

object_name: neuroendocrine carcinoma


subject: UMLS:C4331210

object_name: lung disorder


subject: UMLS:C4331210

object_name: bronchogenic carcinoma


subject: UMLS:C4331210

object_name: intestinal disorder


subject: UMLS:C4331210

object_name: colonic disease


subject: UMLS:C4331210

object_name: esophageal adenocarcinoma


subject: UMLS:C4331210

object_name: lung adenocarcinoma


subject: UMLS:C4331210

object_name: cervical adenocarcinoma


subject: UMLS:C4331210

object_name: adenocarcinoma


subject: UMLS:C4331210

object_name: bile duct adenocarcinoma


subject: UMLS:C4331210

object_name: gastric adenocarcinoma


subject: UMLS:C4331210

object_name: carcinoma


subject: CHEBI:49960

subject_name: Vandetanib

object_name: fallopian tube carcinoma


subject: CHEBI:49960

object_name: fallopian tube cancer


subject: CHEBI:49960

object_name: peritoneum cancer


subject: CHEBI:9168

object_name: IgA Nephropathy


subject: CHEBI:9168

object_name: IgA nephropathy, susceptibility to, 1


subject: CHEBI:35457

subject_name: EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor


subject: UMLS:C0003015


subject: CHEBI:87631

subject_name: statin


subject: CHEBI:9150

subject_name: Simvastatin


subject: PUBCHEM.COMPOUND:92043599

subject_name: epoetin alfa

object_name: Neoplasm Metastasis


subject: CHEBI:28645

subject_name: FRUCTOSE

object_name: type 2 diabetes mellitus


subject: CHEBI:28645

object_name: Insulin resistance


subject: CHEBI:48095

subject_name: keto-D-fructose


subject: CHEBI:48095


subject: CHEBI:31184

subject_name: alclometasone dipropionate

object_name: psoriasis


subject: CHEBI:31184

object_name: atopic eczema


subject: CHEBI:31184

object_name: dermatitis


subject: CHEBI:31184

object_name: Eczema, CTCAE


subject: CHEBI:35854

subject_name: Valaciclovir

object_name: Facial Paresis


subject: CHEBI:35854

object_name: Bell's palsy


subject: MESH:D012462

subject_name: Saline Solution, Hypertonic

object_name: Hemorrhagic Shock


subject: UNII:3A189DH42V

subject_name: Alemtuzumab

object_name: anemia


subject: UNII:3A189DH42V

object_name: Anemia, CTCAE


subject: UMLS:C0004149

subject_name: ATGAM

object_name: Childhood Neuroblastoma


subject: UMLS:C0004149

object_name: neuroblastoma


subject: UMLS:C0004149

object_name: leukemia


subject: UMLS:C0004149

object_name: childhood leukemia


subject: UMLS:C0004149

object_name: adult lymphoma


subject: UMLS:C0004149

object_name: lymphoma


subject: UMLS:C0004149

object_name: pediatric lymphoma


subject: UMLS:C0004149


subject: UMLS:C0004149


subject: CHEBI:82339

subject_name: Merphalan


subject: CHEBI:82339


subject: CHEBI:28876

subject_name: Melphalan


subject: CHEBI:28876


subject: CHEBI:8107

subject_name: Phenytoin

object_name: immunodeficiency disease


subject: CHEBI:8107


subject: CHEBI:8107


subject: CHEBI:8107


subject: CHEBI:8107


subject: UMLS:C0359156

subject_name: Thymoglobulin


subject: UMLS:C0359156


subject: CHEBI:9570

subject_name: Thiotepa


subject: CHEBI:9570


subject: CHEBI:167574

subject_name: Semaglutide

object_name: Inflammation


subject: CHEBI:167574

object_name: Intestinal mucositis


subject: CHEBI:33569

subject_name: noradrenaline

object_name: brain neoplasm


subject: CHEBI:18357

subject_name: Norepinephrine


subject: UMLS:C5959206

subject_name: Anti-CD30 Antibody-drug Conjugate SGN-35C

object_name: mature T-cell and NK-cell non-Hodgkin lymphoma


subject: UMLS:C5959206

object_name: primary cutaneous peripheral T-cell lymphoma not otherwise specified


subject: UMLS:C5959206

object_name: Hodgkin Disease


subject: UMLS:C5959206

object_name: diffuse large B-cell lymphoma


subject: UMLS:C5959206

object_name: anaplastic large cell lymphoma


subject: UMLS:C2830052

object_name: plasma cell myeloma


subject: CHEBI:37941

subject_name: Clopidogrel

object_name: hypertension


subject: CHEBI:37941

object_name: Hypertension, CTCAE


subject: CHEBI:91432

subject_name: Brivanib

object_name: Childhood Soft Tissue Sarcoma


subject: CHEBI:91432

object_name: Adult Soft Tissue Sarcoma


subject: CHEBI:91432

object_name: sarcoma


subject: CHEBI:91432

object_name: Non-Metastatic Childhood Soft Tissue Sarcoma


subject: CHEBI:91432

object_name: soft tissue sarcoma


subject: CHEBI:91432

object_name: transitional cell carcinoma


subject: UMLS:C5882632

subject_name: AC220 compound

object_name: Solid Neoplasm


subject: CHEBI:90217

subject_name: Quizartinib


subject: UMLS:C2825220

subject_name: TRK Inhibitor AZD6918


subject: CHEBI:16664

subject_name: Albendazole

object_name: ancylostomiasis


subject: CHEBI:16664

object_name: Pediculosis


subject: MESH:C000621664

subject_name: Naltrexone-Bupropion combination

object_name: Blood Pressure Finding


subject: MESH:C000621664

object_name: Systemic arterial pressure


subject: CHEBI:49040

subject_name: Ezetimibe

object_name: diabetic polyneuropathy


subject: CHEBI:49040

object_name: Increased reactive oxygen species production


subject: CHEBI:9150

subject_name: Simvastatin


subject: CHEBI:38545

subject_name: Rosuvastatin


subject: CHEBI:38545


subject: CHEBI:32551

object_name: schizophrenia


subject: CHEBI:29967

subject_name: L-lysine residue


subject: CHEBI:133538

subject_name: Lysine


subject: UMLS:C0024337

subject_name: lysine


subject: UMLS:C4527193

object_name: HIV infection


subject: UMLS:C4527193

object_name: HIV-1 infection


subject: UMLS:C1704298

subject_name: Recombinant Luteinizing Hormone

object_name: infertility


subject: CHEBI:4910

subject_name: Etomidate

object_name: Induced Abortion Finding


subject: CHEBI:182080

subject_name: Pentazocine


subject: CHEBI:182080

object_name: no feeling or sensation of skin


subject: CHEBI:182080

object_name: Sensory Loss


subject: CHEBI:38545

object_name: congestive heart failure


subject: UMLS:C0974143

subject_name: Aloe vera gel

object_name: Wounds and Injuries


subject: CHEBI:6605

subject_name: lysergide

object_name: alcohol dependence


subject: PR:000006595

subject_name: deoxyribonuclease gamma


subject: CHEBI:68845

subject_name: Azilsartan medoxomil

object_name: proteinuria


subject: CHEBI:68845

object_name: Proteinuria of undiagnosed cause


subject: CHEBI:68845

object_name: Proteinuria, CTCAE 3.0


subject: CHEBI:68845

object_name: Proteinuria, CTCAE 5.0


subject: CHEBI:68845

object_name: Blood Pressure Finding


subject: CHEBI:68845

object_name: Systemic arterial pressure


subject: CHEBI:68845

object_name: diabetic kidney disease


subject: CHEBI:68845

object_name: Abnormal renal physiology


subject: UMLS:C3883356

subject_name: Lipid Emulsion

object_name: Chronic uremia


subject: CHEBI:90

subject_name: Epicatechin

object_name: hypertension


subject: CHEBI:90

object_name: Hypertension, CTCAE


subject: CHEBI:90

object_name: coronary microvascular disorder


subject: CHEBI:15600

subject_name: Cianidanol


subject: CHEBI:15600


subject: CHEBI:15600


subject: CHEBI:57694


subject: CHEBI:57694


subject: CHEBI:57694


subject: CHEBI:16243

subject_name: Quercetin


subject: CHEBI:16243


subject: CHEBI:16243


subject: UMLS:C4329321

object_name: brain neoplasm


subject: CHEBI:42941

object_name: Stage IV Gallbladder Cancer AJCC v8


subject: CHEBI:42941

object_name: Stage IIB Gallbladder Cancer AJCC v8


subject: CHEBI:42941

object_name: gallbladder cancer


subject: CHEBI:42941

object_name: Stage IIA Gallbladder Cancer AJCC v8


subject: CHEBI:42941

object_name: Stage III Gallbladder Cancer AJCC v8


subject: CHEBI:42941

object_name: Stage 0 Gallbladder Cancer AJCC v8


subject: CHEBI:42941

object_name: gallbladder carcinoma


subject: CHEBI:42941

object_name: carcinoma


subject: UNII:B2K5L1L8S9

subject_name: Surufatinib


subject: UNII:B2K5L1L8S9


subject: UNII:B2K5L1L8S9


subject: UNII:B2K5L1L8S9


subject: UNII:B2K5L1L8S9


subject: UNII:B2K5L1L8S9


subject: UNII:B2K5L1L8S9


subject: UNII:B2K5L1L8S9


subject: GTOPDB:9592

subject_name: tislelizumab


subject: GTOPDB:9592


subject: GTOPDB:9592


subject: GTOPDB:9592


subject: GTOPDB:9592


subject: GTOPDB:9592


subject: GTOPDB:9592


subject: GTOPDB:9592


subject: CHEMBL.COMPOUND:CHEMBL4297840

subject_name: TISLELIZUMAB


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: CHEBI:29287

subject_name: Gold

object_name: chronic obstructive pulmonary disease


subject: CHEBI:5959

subject_name: Irbesartan

object_name: heart failure


subject: CHEBI:63115

subject_name: Fingolimod

object_name: type 2 diabetes mellitus


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: Infusion reaction


subject: UMLS:C3827082


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab


subject: UNII:28X28X9OKV

subject_name: Durvalumab


subject: UMLS:C3641122


subject: CHEBI:231679

subject_name: ipilimumab


subject: CHEBI:231614

subject_name: Nivolumab


subject: UMLS:C2346820


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: CHEBI:231601

subject_name: trastuzumab


subject: UNII:SE2KH7T06F


subject: UMLS:C0338204

subject_name: Herceptin


subject: UNII:19FUJ2C58T

subject_name: Ginkgo biloba

object_name: peripheral vascular disease


subject: UNII:19FUJ2C58T

object_name: intermittent vascular claudication


subject: CHEBI:50841

subject_name: Loxapine

object_name: Haloperidol causing adverse effects in therapeutic use


subject: CHEBI:50841

object_name: Lorazepam causing adverse effects in therapeutic use


subject: UNII:T41737F88A

subject_name: Tisotumab vedotin

object_name: Childhood Solid Neoplasm


subject: UNII:T41737F88A

object_name: Adult Solid Neoplasm


subject: UNII:T41737F88A

object_name: Solid Neoplasm


subject: UMLS:C3827178

subject_name: HuMax-TF-ADC


subject: UMLS:C3827178


subject: UMLS:C3827178


subject: CHEBI:168396

subject_name: Mycophenolic acid

object_name: Recurrent Childhood Gliosarcoma


subject: CHEBI:168396

object_name: Recurrent Gliosarcoma


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: CHEBI:8764


subject: UNII:5S371K6132

subject_name: Rivoceranib

object_name: Cervical carcinoma stage IVB


subject: UNII:5S371K6132

object_name: Stage IVB Cervical Cancer AJCC v6 and v7


subject: UNII:5S371K6132

object_name: Stage IVB Cervical Cancer AJCC v8


subject: GTOPDB:9758

subject_name: camrelizumab


subject: GTOPDB:9758


subject: GTOPDB:9758


subject: UNII:73096E137E


subject: UNII:73096E137E


subject: UNII:73096E137E


subject: UMLS:C4085979


subject: UMLS:C4085979


subject: UMLS:C4085979


subject: UMLS:C0599278

subject_name: radioligand

object_name: Alzheimer disease


subject: PUBCHEM.COMPOUND:91867649


subject: CHEBI:36929

subject_name: carbon-11 atom


subject: UMLS:C2715224


subject: MESH:C582909


subject: CHEBI:70839

subject_name: Dasatinib

object_name: Metastatic malignant neoplasm to pancreas


subject: CHEBI:190514


subject: CHEBI:49375


subject: CHEBI:40279

subject_name: Allopurinol

object_name: type 1 diabetes mellitus


subject: CHEBI:82339

subject_name: Merphalan

object_name: Effects of chemotherapy


subject: CHEBI:28876

subject_name: Melphalan


subject: CHEBI:134990

subject_name: Agomelatine

object_name: schizoaffective disorder


subject: CHEBI:134990

object_name: schizophrenia 18


subject: CHEBI:134990

object_name: delusional disorder


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED

object_name: Childhood Gliomatosis Cerebri


subject: UMLS:C0919079

object_name: gliomatosis cerebri


subject: CHEBI:72564

subject_name: Temozolomide


subject: CHEBI:72564


subject: CHEBI:49662

subject_name: Indomethacin

object_name: Prostate cancer recurrent


subject: CHEBI:49662

object_name: Stage IV Prostate Cancer AJCC v6


subject: CHEBI:49662

object_name: Carcinoma of the prostate stage IV


subject: CHEBI:49662

object_name: Stage IV Prostate Cancer AJCC v8


subject: CHEBI:49662

object_name: metastatic prostate carcinoma


subject: UNII:Q46947FE7K

subject_name: Peginterferon alfa-2a

object_name: chronic hepatitis D infection


subject: UNII:PP0SHH6V16

subject_name: Alirocumab

object_name: nephrotic syndrome


subject: UNII:PP0SHH6V16

object_name: Nephrotic Syndrome, CTCAE


subject: UMLS:C4548849

object_name: Severe postnatal depression


subject: CHEBI:50169

subject_name: Brexanolone


subject: RXCUI:659877

subject_name: Gardasil

object_name: vaccinia


subject: CHEBI:4636

subject_name: Diphenhydramine

object_name: rhinitis


subject: CHEBI:4636

object_name: Inflammation


subject: CHEBI:4636

object_name: Cough


subject: CHEBI:4636

object_name: Cough, CTCAE


subject: CHEBI:93837

subject_name: Dropropizine


subject: CHEBI:93837


subject: CHEBI:93837


subject: CHEBI:93837


subject: CHEBI:51209

subject_name: Pseudoephedrine


subject: CHEBI:51209


subject: CHEBI:51209


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin

object_name: appendiceal neoplasm


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: CHEBI:8988


subject: CHEBI:80630

subject_name: Irinotecan


subject: UNII:H4T32JIH01

subject_name: FORDADISTROGENE MOVAPARVOVEC

object_name: Duchenne muscular dystrophy


subject: CHEBI:63622

subject_name: Sotalol

object_name: Atrial arrhythmia


subject: CHEBI:135949

subject_name: Ambrisentan

object_name: scleroderma


subject: CHEBI:131174

subject_name: Navitoclax

object_name: Adult Myelodysplastic Syndrome


subject: CHEBI:131174

object_name: childhood myelodysplastic syndrome


subject: CHEBI:131174

object_name: Myelodysplastic Syndrome, CTCAE


subject: CHEBI:131174

object_name: Refractory Myelodysplastic Syndrome


subject: CHEBI:131174

object_name: Recurrent Myelodysplastic Syndrome


subject: CHEBI:131174

object_name: Recurrent Acute Myeloid Leukemia with Myelodysplasia-Related Changes


subject: CHEBI:50826

subject_name: silver nanoparticle

object_name: bacterial infectious disease


subject: CHEBI:50826

object_name: Fungal foot infection


subject: MESH:C586932

subject_name: colloidal silver


subject: MESH:C586932


subject: CHEBI:30512

subject_name: Silver


subject: CHEBI:30512


subject: CHEBI:49468

subject_name: Silver cation


subject: CHEBI:49468


subject: MESH:D006495

subject_name: Heparin, Low-Molecular-Weight

object_name: Repeated implantation failure


subject: UMLS:C3536766

subject_name: Low Molecular Weight Heparin [EPC]


subject: UMLS:C3896810

object_name: glioblastoma


subject: UMLS:C3896810

object_name: Childhood Glioblastoma


subject: UMLS:C3896810

object_name: adult glioblastoma


subject: UMLS:C3896810

object_name: Brain Stem Glioblastoma


subject: UMLS:C3896810

object_name: glioma susceptibility 1


subject: UMLS:C2985191


subject: UMLS:C2985191


subject: UMLS:C2985191


subject: UMLS:C2985191


subject: UMLS:C2985191


subject: UMLS:C5856661

subject_name: Myrciaria dubia Prebiotic Supplement

object_name: nonpapillary renal cell carcinoma


subject: UMLS:C5856661

object_name: clear cell renal carcinoma


subject: UMLS:C5856661

object_name: sarcomatoid renal cell carcinoma


subject: UMLS:C5856661

object_name: Stage IV Renal Cell Cancer AJCC v8


subject: UMLS:C5856661

object_name: Stage III Renal Cell Cancer AJCC v8


subject: GTOPDB:12347

subject_name: penpulimab

object_name: nasopharyngeal neoplasm


subject: CHEMBL.COMPOUND:CHEMBL4297571

subject_name: PENPULIMAB


subject: UMLS:C4723695


subject: CHEBI:50730

subject_name: Montelukast

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:50730

object_name: obesity


subject: CHEBI:50730

object_name: Obesity, CTCAE


subject: CHEBI:50730

object_name: Inflammation


subject: CHEBI:6456

subject_name: Lidocaine

object_name: Spastic Dysphonia


subject: CHEBI:6456

object_name: Dysphonia


subject: UNII:68AYS9A614

subject_name: CEDIRANIB MALEATE

object_name: Recurrent Childhood Glioblastoma


subject: UNII:68AYS9A614

object_name: Recurrent Glioblastoma


subject: UMLS:C2711999

subject_name: cediranib maleate


subject: UMLS:C2711999


subject: UMLS:C5785427

subject_name: CDK4/6 Inhibitor SPH4336

object_name: dedifferentiated liposarcoma


subject: UMLS:C3181238

subject_name: focetria

object_name: swine influenza


subject: PUBCHEM.COMPOUND:54751657

subject_name: Minocin

object_name: fragile X syndrome


subject: CHEBI:50697

subject_name: minocycline hydrochloride


subject: UMLS:C3248648

subject_name: Injection, minocycline hydrochloride, 1 mg administered


subject: DRUGBANK:DB17523

object_name: pancreatic neoplasm


subject: DRUGBANK:DB17523

object_name: exocrine pancreatic carcinoma


subject: DRUGBANK:DB17523

object_name: malignant pancreatic neoplasm


subject: UMLS:C0007507

subject_name: Antigens, CD25

object_name: kidney failure


subject: UMLS:C0007507

object_name: end stage renal failure


subject: UMLS:C0007507

object_name: Chronic uremia


subject: PR:000001380

subject_name: interleukin-2 receptor subunit alpha


subject: PR:000001380


subject: PR:000001380


subject: CHEBI:4055

subject_name: Cytisine


subject: UMLS:C4721781

subject_name: Tedopi

object_name: Metastatic non-small cell lung cancer


subject: PUBCHEM.COMPOUND:11756905

subject_name: Delamanid

object_name: bacterial infectious disease


subject: CHEBI:45285

subject_name: Pyrazinamide


subject: CHEMBL.COMPOUND:CHEMBL5315087

subject_name: PROTEIN C CONCENTRATE (HUMAN)

object_name: septic shock


subject: CHEMBL.COMPOUND:CHEMBL5315087

object_name: Sepsis


subject: CHEMBL.COMPOUND:CHEMBL5315087

object_name: Sepsis, CTCAE


subject: CHEBI:9434

subject_name: Telmisartan

object_name: polycystic kidney disease


subject: UMLS:C5555561

subject_name: Anti-LAG-3 Monoclonal Antibody LBL-007

object_name: Advanced Melanoma


subject: GTOPDB:12989

subject_name: toripalimab


subject: UNII:8JXN261VVA


subject: UMLS:C0812735

subject_name: INJECTION FLUCONAZOLE, 200 MG ADMINISTERED

object_name: graft versus host disease


subject: CHEBI:46081

subject_name: Fluconazole


subject: PUBCHEM.COMPOUND:78357831

subject_name: micafungin


subject: UMLS:C0879264


subject: CHEBI:10023

subject_name: Voriconazole


subject: UNII:Y68179SY2L

object_name: pancreatic neoplasm of uncertain behavior somatostatinoma


subject: UNII:Y68179SY2L

object_name: pancreatic somatostatinoma


subject: UNII:Y68179SY2L

object_name: somatostatinoma


subject: UNII:Y68179SY2L

object_name: childhood medulloblastoma


subject: UNII:Y68179SY2L

object_name: adult medulloblastoma


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: Unresectable Malignant Neoplasm


subject: PUBCHEM.COMPOUND:44602504

subject_name: Etrasimod

object_name: eosinophilic esophagitis


subject: PUBCHEM.COMPOUND:44602504

object_name: Eosinophilic infiltration of the esophagus


subject: CHEBI:75323

subject_name: Lactitol

object_name: Bacterial Colonization


subject: UNII:7N969W8Y4O

object_name: Alzheimer disease


subject: CHEBI:231651

subject_name: Vosaroxin

object_name: acute lymphoblastic leukemia


subject: CHEBI:231651

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: Ann Arbor Stage III Grade 1 Follicular Lymphoma


subject: UNII:DPT0O3T46P

object_name: Stage III Testicular Cancer AJCC v6 and v7


subject: UNII:DPT0O3T46P

object_name: Masaoka-Koga Stage III


subject: CHEBI:7496

subject_name: Nelfinavir

object_name: cervical cancer


subject: CHEBI:7496

object_name: cervical carcinoma


subject: UNII:090IP5RV8F

subject_name: Omadacycline

object_name: cystic fibrosis


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: Relapse multiple myeloma


subject: CHEBI:17061

subject_name: D-Glutamine

object_name: Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone


subject: CHEBI:17061

object_name: childhood malignant fibrous histiocytoma of bone


subject: CHEBI:28300

subject_name: glutamine


subject: CHEBI:28300


subject: CHEBI:18050

subject_name: L-Glutamine


subject: CHEBI:18050


subject: CHEBI:4910

subject_name: Etomidate

object_name: conscious sedation failure during procedure


subject: CHEBI:119915

subject_name: Fentanyl


subject: PUBCHEM.COMPOUND:86291498

object_name: fibromyalgia


subject: PUBCHEM.COMPOUND:60751

subject_name: Temoporfin

object_name: neoplasm


subject: PUBCHEM.COMPOUND:60751

object_name: Tumor Mass


subject: PUBCHEM.COMPOUND:60751

object_name: Klatskin Tumor


subject: PUBCHEM.COMPOUND:60751

object_name: cholangiocarcinoma


subject: CHEBI:9437


subject: CHEBI:9437


subject: CHEBI:9437


subject: CHEBI:9437


subject: UMLS:C5418098

object_name: Adult Solid Neoplasm


subject: CHEBI:74947

subject_name: Thalidomide

object_name: hepatitis C


subject: CHEBI:9014

subject_name: Salsalate

object_name: hypertension


subject: CHEBI:9014

object_name: Hypertension, CTCAE


subject: CHEBI:9014

object_name: Diabetes


subject: CHEBI:9014

object_name: diabetes mellitus


subject: PUBCHEM.COMPOUND:92043599

subject_name: epoetin alfa

object_name: pulmonary hypertension


subject: PUBCHEM.COMPOUND:92043599

object_name: Pulmonary Hypertension, CTCAE


subject: CHEBI:81579

subject_name: Erythropoietin


subject: CHEBI:81579


subject: CHEBI:81579

object_name: sickle cell disease


subject: CHEBI:44423

subject_name: Hydroxyurea

object_name: chronic kidney disease


subject: CHEBI:44423

object_name: Chronic Kidney Disease, CTCAE


subject: RXCUI:597967

subject_name: amlodipine 10 MG / atorvastatin 20 MG Oral Tablet

object_name: outcomes general quality of life


subject: RXCUI:597967

object_name: Perceived quality of life


subject: RXCUI:597967

object_name: Good quality of life


subject: CHEBI:191502

subject_name: MS 3

object_name: acute myeloid leukemia


subject: CHEBI:2687

subject_name: Amsacrine


subject: UMLS:C5856982

object_name: tumor suppressor gene on chromosome 11


subject: UMLS:C5856982

object_name: non-small cell lung carcinoma


subject: UMLS:C5856982

object_name: lung cancer


subject: UMLS:C5856982

object_name: Childhood Breast Carcinoma


subject: UMLS:C5856982

object_name: breast carcinoma


subject: UMLS:C5856982

object_name: breast cancer


subject: GTOPDB:13627

subject_name: zanidatamab

object_name: malignant soft tissue neoplasm


subject: GTOPDB:13627

object_name: sarcoma


subject: UNII:Z20OC92TDI

subject_name: ZANIDATAMAB


subject: UNII:Z20OC92TDI


subject: UMLS:C4331966


subject: UMLS:C4331966


subject: UNII:UG7I3Y42PV

subject_name: Fluoroazomycin arabinoside F-18


subject: UNII:UG7I3Y42PV

object_name: lung neoplasm


subject: UNII:UG7I3Y42PV

object_name: lung carcinoma


subject: UMLS:C1566975


subject: UMLS:C1566975


subject: UMLS:C1566975


subject: CHEBI:9720

subject_name: Trihexyphenidyl

object_name: torsion dystonia 7


subject: CHEBI:34385

subject_name: Dalfampridine

object_name: Guillain-Barre syndrome


subject: CHEBI:34385

object_name: Guillain-Barre Syndrome, CTCAE


subject: DRUGBANK:DB14322

subject_name: Coconut oil

object_name: asthma


subject: UNII:420K487FSG

subject_name: Dupilumab

object_name: Allergy


subject: UNII:420K487FSG

object_name: hypersensitivity reaction disease


subject: UNII:420K487FSG

object_name: Emotional hypersensitivity


subject: UMLS:C3658854


subject: UMLS:C3658854


subject: UMLS:C3658854


subject: PUBCHEM.COMPOUND:60751

object_name: Oropharyngeal squamous cell carcinoma recurrent


subject: PUBCHEM.COMPOUND:60751

object_name: Recurrent Lip and Oral Cavity Squamous Cell Carcinoma


subject: PUBCHEM.COMPOUND:60751

object_name: Oropharyngeal squamous cell carcinoma stage I


subject: PUBCHEM.COMPOUND:60751

object_name: Oropharyngeal squamous cell carcinoma stage II


subject: PUBCHEM.COMPOUND:60751

object_name: Stage I Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: PUBCHEM.COMPOUND:60751

object_name: Stage II Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: PUBCHEM.COMPOUND:60751

object_name: Verrucous carcinoma of the oral cavity stage I


subject: PUBCHEM.COMPOUND:60751

object_name: Verrucous carcinoma of the oral cavity recurrent


subject: PUBCHEM.COMPOUND:60751

object_name: Verrucous carcinoma of the oral cavity stage II


subject: PUBCHEM.COMPOUND:60751

object_name: tongue cancer


subject: PUBCHEM.COMPOUND:60751

object_name: tongue carcinoma


subject: CHEBI:9437


subject: CHEBI:9437


subject: CHEBI:9437


subject: CHEBI:9437


subject: CHEBI:9437


subject: CHEBI:9437


subject: CHEBI:9437


subject: CHEBI:9437


subject: CHEBI:9437


subject: CHEBI:9437


subject: CHEBI:9437


subject: PUBCHEM.COMPOUND:75988815

subject_name: Elafibranor

object_name: sclerosing cholangitis


subject: PUBCHEM.COMPOUND:75988815

object_name: primary sclerosing cholangitis


subject: CHEBI:78870

subject_name: sodium nitrite

object_name: coronary artery disorder


subject: CHEBI:78870

object_name: aneurysm


subject: CHEBI:78870

object_name: heart disorder


subject: CHEBI:78870

object_name: arteriosclerosis disorder


subject: CHEBI:78870

object_name: atherosclerosis


subject: UMLS:C5555013

subject_name: Anti-mucin-1/PE Immunoconjugate BM7PE

object_name: metastatic colorectal cancer


subject: CHEBI:36796

subject_name: duloxetine

object_name: alcohol abuse


subject: CHEBI:36796

object_name: alcohol dependence


subject: CHEBI:18067

subject_name: Phylloquinone

object_name: end stage renal failure


subject: CHEBI:18067

object_name: Chronic uremia


subject: UMLS:C0718247

subject_name: Active brand of pseudoephedrine-triprolidine

object_name: glucose intolerance


subject: UMLS:C0718247

object_name: Glucose Intolerance, CTCAE


subject: UMLS:C1948073

object_name: uveal melanoma


subject: UMLS:C1446945

subject_name: Vitis vinifera antigen

object_name: Sports Injury


subject: UMLS:C4724780

subject_name: Vitis vinifera extract


subject: CHEBI:9907

subject_name: ursodiol

object_name: hepatitis D


subject: UMLS:C1571394

object_name: acquired polycythemia vera


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim

object_name: Non-small cell lung cancer stage IIIB


subject: UNII:PVI5M0M1GW

object_name: Non-small cell lung cancer stage IIIA


subject: UNII:PVI5M0M1GW

object_name: lung large cell carcinoma


subject: UNII:PVI5M0M1GW

object_name: squamous cell lung carcinoma


subject: UNII:PVI5M0M1GW

object_name: minimally invasive lung adenocarcinoma


subject: UNII:PVI5M0M1GW

object_name: adenosquamous lung carcinoma


subject: UNII:PVI5M0M1GW

object_name: lung adenocarcinoma


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: UNII:3A58010674

subject_name: Pegfilgrastim


subject: PUBCHEM.COMPOUND:70105374

subject_name: Pitavastatin Lactone

object_name: B-cell chronic lymphocytic leukemia


subject: PUBCHEM.COMPOUND:70105374

object_name: acute myeloid leukemia by FAB classification


subject: PUBCHEM.COMPOUND:70105374

object_name: acute myeloid leukemia


subject: PUBCHEM.COMPOUND:70105374

object_name: Recurrent Chronic Lymphoid Leukemia


subject: PUBCHEM.COMPOUND:70105374

object_name: Chronic lymphocytic leukaemia refractory


subject: PUBCHEM.COMPOUND:70105374

object_name: chronic leukemia


subject: PUBCHEM.COMPOUND:70105374

object_name: adult acute myeloid leukemia


subject: CHEBI:32020

subject_name: Pitavastatin


subject: CHEBI:32020


subject: CHEBI:32020


subject: CHEBI:32020


subject: CHEBI:32020


subject: CHEBI:32020


subject: CHEBI:32020


subject: UNII:C21EZR41AY

subject_name: Zalypsis

object_name: adult lymphoma


subject: UNII:C21EZR41AY

object_name: lymphoma


subject: UNII:C21EZR41AY

object_name: pediatric lymphoma


subject: UNII:C21EZR41AY

object_name: Solid Neoplasm


subject: UMLS:C2932376

subject_name: XOMA 052

object_name: Behcet disease


subject: UMLS:C2932376

object_name: Muckle-Wells syndrome


subject: UMLS:C5706513

subject_name: Stapokibart

object_name: chronic obstructive pulmonary disease


subject: PUBCHEM.COMPOUND:124037376

object_name: spinal cord injury


subject: CHEMBL.COMPOUND:CHEMBL4297775


subject: UMLS:C3712782


subject: UMLS:C2703079

object_name: Advanced cancer


subject: CHEBI:85164

subject_name: Nintedanib

object_name: adhesions of uterus


subject: PUBCHEM.COMPOUND:45382195

subject_name: Thymosin Beta 4

object_name: dry eye syndrome


subject: PUBCHEM.COMPOUND:45382195

object_name: Dry Eye, CTCAE


subject: PUBCHEM.COMPOUND:45382195

object_name: Dryness of eye


subject: PUBCHEM.COMPOUND:45382195

object_name: xerophthalmia


subject: PUBCHEM.COMPOUND:45382195

object_name: Dry Eye Syndrome, CTCAE


subject: UMLS:C0076616

subject_name: Thymosin beta-4


subject: UMLS:C0076616


subject: UMLS:C0076616


subject: UMLS:C0076616


subject: UMLS:C0076616


subject: CHEBI:2639

subject_name: Amiloride

object_name: attention deficit hyperactivity disorder, inattentive type


subject: CHEBI:2639


subject: CHEBI:189965

subject_name: Prosapogenin

object_name: colorectal cancer


subject: CHEBI:189965

object_name: colorectal carcinoma


subject: CHEBI:189965

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: DRUGBANK:DB01404

subject_name: Ginseng


subject: DRUGBANK:DB01404


subject: DRUGBANK:DB01404


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: septic shock


subject: CHEBI:499361

subject_name: Aprepitant

object_name: lymphoma, non-Hodgkin, familial


subject: CHEBI:499361

object_name: non-Hodgkin lymphoma


subject: CHEBI:7773

subject_name: Ondansetron

object_name: plasma cell myeloma


subject: CHEBI:51041

subject_name: Acamprosate

object_name: cocaine dependence


subject: UMLS:C5855548

subject_name: Copper Cu 64 FBP8

object_name: pulmonary embolism


subject: UMLS:C5855548

object_name: venous thromboembolism


subject: UMLS:C5855548

object_name: thrombophilia due to thrombin defect


subject: UMLS:C5855548

object_name: Deep vein thrombosis of lower limb


subject: UMLS:C5855548

object_name: Deep venous thrombosis


subject: UNII:LKC0U3A8NJ

subject_name: Evolocumab

object_name: Secondary malignant neoplasm of lung


subject: CHEBI:5195

subject_name: furazolidone

object_name: Nonulcer dyspepsia


subject: CHEBI:31348

subject_name: Capecitabine

object_name: malignant tumor of nasopharynx


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations

object_name: Neoplasm of the genitourinary tract


subject: UMLS:C0013227

object_name: benign urinary system neoplasm


subject: UMLS:C0013227

object_name: urinary system neoplasm


subject: UMLS:C0013227

object_name: kidney neoplasm


subject: UMLS:C0013227

object_name: childhood kidney neoplasm


subject: UNII:5ZHA5P4PFX

subject_name: Dalpiciclib

object_name: Carcinoma breast stage IV


subject: UNII:NZZ7UWE8JN

object_name: hepatitis B


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: Recurrent Head and Neck Carcinoma


subject: UNII:DPT0O3T46P

object_name: EGFR gene mutation


subject: UNII:DPT0O3T46P

object_name: BRAF gene mutation


subject: UNII:DPT0O3T46P

object_name: ROS1 Gene Mutation


subject: UMLS:C3640822

object_name: Non-small cell lung cancer stage III


subject: UMLS:C3640822


subject: UMLS:C3640822

object_name: Head and neck cancer metastatic


subject: UMLS:C3640822


subject: UMLS:C3640822


subject: UMLS:C3640822


subject: UMLS:C3640822

object_name: ALK gene mutation


subject: CHEBI:9943

subject_name: Venlafaxine

object_name: obstructive sleep apnea syndrome


subject: CHEBI:94366

subject_name: itraconazole

object_name: Myelodysplasia


subject: GTOPDB:13084

subject_name: narlumosbart

object_name: bone giant cell tumor


subject: CHEMBL.COMPOUND:CHEMBL5314993

subject_name: NARLUMOSBART


subject: UMLS:C5783725

subject_name: Narlumosbart


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Self efficacy (finding)


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: CHEBI:5103

subject_name: Flumazenil

object_name: Flumazenil adverse reaction


subject: CHEBI:15365

subject_name: Aspirin

object_name: cataract


subject: CHEBI:15365

object_name: Cataract, CTCAE 3.0


subject: CHEBI:15365

object_name: Cataract, CTCAE 5.0


subject: CHEBI:15365

object_name: cataract on exam (physical finding)


subject: UNII:37KZM6S21G

subject_name: cerebrolysin

object_name: Bell's palsy


subject: UMLS:C0055108


subject: UMLS:C3828699

subject_name: Oraxol

object_name: skin angiosarcoma


subject: CHEBI:68558

subject_name: Ticagrelor

object_name: chronic obstructive pulmonary disease


subject: PUBCHEM.COMPOUND:3685

object_name: Childhood Acute Promyelocytic Leukemia with PML-RARA


subject: PUBCHEM.COMPOUND:3685

object_name: myeloid neoplasm


subject: CHEBI:42068

subject_name: Idarubicin


subject: CHEBI:42068


subject: CHEBI:31822

subject_name: MERCAPTOPURINE


subject: CHEBI:2208

subject_name: Mercaptopurine


subject: PUBCHEM.COMPOUND:5458171

subject_name: MITOXANTRONE HYDROCHLORIDE


subject: CHEBI:50729

subject_name: Mitoxantrone


subject: CHEBI:15367

subject_name: Tretinoin


subject: CHEBI:50648

subject_name: Alitretinoin


subject: CHEMBL.COMPOUND:CHEMBL2109564

object_name: rabies


subject: MESH:C524361

subject_name: DtwP-HepB-Hib vaccine

object_name: hepatitis B


subject: MESH:C524361

object_name: diphtheria


subject: MESH:C524361

object_name: pertussis


subject: MESH:C524361

object_name: tetanus


subject: UNII:7SQY4ZUD30

subject_name: Dinutuximab

object_name: Resectable Osteosarcoma


subject: GTOPDB:12652

subject_name: magrolimab

object_name: Refractory Neuroblastoma


subject: GTOPDB:12652

object_name: Neuroblastoma recurrent


subject: GTOPDB:12652

object_name: High Risk Neuroblastoma


subject: GTOPDB:12652

object_name: Osteosarcoma recurrent


subject: GTOPDB:12652


subject: UNII:90YIEHRFJ9


subject: UNII:90YIEHRFJ9


subject: UNII:90YIEHRFJ9


subject: UNII:90YIEHRFJ9


subject: UNII:90YIEHRFJ9


subject: UMLS:C3896840


subject: UMLS:C3896840


subject: UMLS:C3896840


subject: UMLS:C3896840


subject: UMLS:C3896840


subject: CHEBI:8228

subject_name: Pioglitazone

object_name: Pulmonary Hypertension, CTCAE


subject: UMLS:C2346449

subject_name: OSI 906

object_name: Childhood Breast Carcinoma


subject: UMLS:C2346449

object_name: breast carcinoma


subject: UMLS:C2346449

object_name: breast cancer


subject: UMLS:C5854600

subject_name: CBP/p300 Bromodomain Inhibitor AUR-107

object_name: Recurrent Malignant Solid Neoplasm


subject: UMLS:C5854519

subject_name: ARG1/ARG2 Inhibitor OATD-02

object_name: Metastatic Colorectal Carcinoma


subject: UMLS:C5854519

object_name: stage IV pancreatic cancer


subject: UMLS:C5854519

object_name: Metastatic Renal Cell Carcinoma


subject: UMLS:C5854519

object_name: Metastatic Renal Cell Cancer


subject: UMLS:C5854519

object_name: Stage IV Ovarian Carcinoma


subject: UMLS:C5854519

object_name: Advanced renal cell carcinoma


subject: UMLS:C5854519

object_name: Advanced Colorectal Carcinoma


subject: UMLS:C5854519

object_name: Advanced Pancreatic Carcinoma


subject: UMLS:C5854519

object_name: Advanced Ovarian Carcinoma


subject: CHEBI:231601

subject_name: trastuzumab

object_name: Locally Advanced HER2-Positive Breast Carcinoma


subject: UNII:SE2KH7T06F


subject: UMLS:C0338204

subject_name: Herceptin


subject: UNII:234248D0HH

subject_name: Tucatinib


subject: PUBCHEM.COMPOUND:44424639

subject_name: Vinorelbine


subject: CHEBI:93786


subject: UNII:CWG62Q1VTB

subject_name: Sitravatinib

object_name: esophageal squamous cell carcinoma


subject: CHEBI:16866

subject_name: alizarin

object_name: periodontitis


subject: UNII:4NJ842U6BZ

subject_name: azimexon


subject: PR:000022182

subject_name: regulatory protein AtoC


subject: UNII:IYT6MP4NS9

object_name: coronary artery disorder


subject: UNII:IYT6MP4NS9

object_name: acute coronary syndrome


subject: UNII:IYT6MP4NS9

object_name: coronary atherosclerosis


subject: UNII:IYT6MP4NS9

object_name: heart disorder


subject: UNII:IYT6MP4NS9

object_name: myocardial ischemia


subject: UNII:IYT6MP4NS9

object_name: peripheral vascular disease


subject: UNII:IYT6MP4NS9

object_name: arteriosclerosis disorder


subject: UMLS:C4519750


subject: UMLS:C4519750


subject: UMLS:C4519750


subject: UMLS:C4519750


subject: UMLS:C4519750


subject: UMLS:C4519750


subject: UMLS:C4519750


subject: UMLS:C2830069

subject_name: Smoothened Antagonist LDE225

object_name: Cirrhosis


subject: UMLS:C2830069

object_name: liver cirrhosis


subject: CHEBI:90863

subject_name: Sonidegib


subject: CHEBI:90863


subject: CHEBI:62880

subject_name: Veliparib

object_name: malignant testicular germ cell tumor


subject: CHEBI:62880

object_name: neoplasm of testis


subject: CHEBI:3219

subject_name: Bupropion

object_name: chronic kidney disease


subject: UMLS:C5908013

subject_name: Nanoparticle Encapsulated AChR Epitopes CNP-106

object_name: Generalized myasthenia


subject: UMLS:C5908013

object_name: myasthenia gravis


subject: UMLS:C5908013

object_name: Myasthenia Gravis, CTCAE


subject: UMLS:C5908013

object_name: AChR myasthenia gravis


subject: UMLS:C5908013

object_name: Muscle-Specific Receptor Tyrosine Kinase Myasthenia Gravis


subject: PUBCHEM.COMPOUND:71622431

subject_name: ivarmacitinib

object_name: primary cutaneous peripheral T-cell lymphoma not otherwise specified


subject: UMLS:C5565994


subject: CHEBI:6456

subject_name: Lidocaine

object_name: Brain freeze


subject: UMLS:C1971782

subject_name: DEXTROAMPHETAMINE SULFATE, 5 MG ADMINISTERED

object_name: opiate dependence


subject: CHEBI:4469

subject_name: dexamfetamine


subject: PUBCHEM.COMPOUND:156963654

subject_name: Sacituzumab govitecan

object_name: neoplastic meningitis


subject: UNII:DA64T2C2IO

subject_name: SACITUZUMAB


subject: UMLS:C3640943


subject: CHEBI:31236

subject_name: Aripiprazole

object_name: Anorexia


subject: PUBCHEM.COMPOUND:27991

subject_name: dAVP

object_name: Hemophilia A carrier


subject: PUBCHEM.COMPOUND:16051933

subject_name: DESMOPRESSIN


subject: UMLS:C2987384

subject_name: BMN 673

object_name: triple-negative breast carcinoma


subject: CHEBI:71219

subject_name: Pazopanib

object_name: malignant mesothelioma


subject: CHEBI:71219

object_name: Mesothelioma malignant recurrent


subject: CHEBI:71219

object_name: Mesothelioma malignant localised


subject: CHEBI:49662

subject_name: Indomethacin

object_name: Other acute postoperative pain


subject: CHEBI:30742

subject_name: macrogol

object_name: cystic fibrosis


subject: UNII:FZ46ONU496

subject_name: Macrogol 4000


subject: UNII:4R4HFI6D95

subject_name: polyethylene glycol 4000


subject: CHEBI:18248

subject_name: Iron

object_name: Iron deficiency without anemia


subject: CHEBI:29034

subject_name: Ferric cation


subject: UMLS:C1166521

subject_name: Ferrum metallicum, Homeopathic preparation


subject: UMLS:C3714701

subject_name: Iron Drug Class


subject: CHEBI:167309

subject_name: Methadone

object_name: Control of hip fracture risk


subject: CHEBI:167309

object_name: hip fracture


subject: CHEBI:167574

subject_name: Semaglutide

object_name: arteriosclerosis disorder


subject: CHEBI:167574

object_name: atherosclerosis


subject: UNII:6ZA31Y954Z

subject_name: Brodalumab

object_name: Chronic small plaque psoriasis


subject: CHEBI:231087

subject_name: Trilaciclib

object_name: urothelial carcinoma


subject: CHEBI:231087

object_name: transitional cell carcinoma


subject: CHEBI:231087

object_name: Bladder cancer stage IV


subject: CHEBI:231087

object_name: Chemotherapy induced neutropenia


subject: CHEBI:3752

subject_name: Clomifene

object_name: Non-obstructive azoospermia


subject: CHEBI:3752

object_name: hypogonadism


subject: CHEBI:134718

subject_name: Safinamide

object_name: kidney failure


subject: CHEBI:18246

subject_name: Cellulose

object_name: Physical trauma


subject: CHEBI:18246

object_name: Injury


subject: CHEBI:18246

object_name: Trauma


subject: CHEBI:18246

object_name: Hemorrhage


subject: CHEBI:474053

subject_name: Cefazolin

object_name: Knee arthropathy


subject: CHEBI:4672

subject_name: Docetaxel

object_name: invasive lobular breast carcinoma


subject: CHEBI:4672

object_name: mixed lobular and ductal breast carcinoma


subject: CHEBI:47898

subject_name: Epirubicin


subject: CHEBI:47898


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4026


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: PUBCHEM.COMPOUND:25136944

subject_name: Navelbine

object_name: inflammatory breast carcinoma


subject: PUBCHEM.COMPOUND:25136944


subject: PUBCHEM.COMPOUND:25136944


subject: PUBCHEM.COMPOUND:44424639

subject_name: Vinorelbine


subject: PUBCHEM.COMPOUND:44424639


subject: PUBCHEM.COMPOUND:44424639


subject: CHEBI:93786


subject: CHEBI:93786


subject: CHEBI:93786


subject: CHEBI:31348

subject_name: Capecitabine


subject: CHEBI:31348


subject: CHEBI:231601

subject_name: trastuzumab


subject: CHEBI:231601


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UMLS:C0338204

subject_name: Herceptin


subject: UMLS:C0338204


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab


subject: UNII:2S9ZZM9Q9V


subject: CHEBI:22966

subject_name: butylstannane

object_name: tuberculosis


subject: CHEBI:22966

object_name: HIV infection


subject: CHEBI:34292

subject_name: captax


subject: CHEBI:34292


subject: PUBCHEM.COMPOUND:67454400

subject_name: reldesemtiv

object_name: chronic obstructive pulmonary disease


subject: UNII:4S0HBYW6QE

subject_name: Reldesemtiv


subject: UMLS:C3542463

subject_name: tbo-filgrastim

object_name: non-Hodgkin lymphoma


subject: UMLS:C3542463

object_name: plasma cell myeloma


subject: PR:000013344

object_name: type 2 diabetes mellitus


subject: CHEBI:37941

subject_name: Clopidogrel

object_name: coronary aneurysm


subject: CHEBI:37941

object_name: Coronary artery ectasia


subject: CHEBI:32588

subject_name: Potassium chloride

object_name: Conn's syndrome


subject: CHEBI:32588

object_name: Hypokalemia, CTCAE


subject: MESH:D022401

subject_name: Meningococcal Vaccines

object_name: pertussis


subject: MESH:D022401

object_name: meningitis


subject: MESH:D022401

object_name: Meningitis, CTCAE


subject: MESH:D022401

object_name: meningitis; preventive immunization


subject: UNII:HX101E7L6S

subject_name: oregovomab

object_name: ovarian epithelial tumor


subject: UMLS:C0664206

subject_name: Ovarex


subject: CHEMBL.COMPOUND:CHEMBL1200571

subject_name: GADOBENATE DIMEGLUMINE

object_name: liver carcinoma


subject: UNII:3Q6PPC19PO


subject: UMLS:C0753357

subject_name: MultiHance


subject: CHEBI:4856

subject_name: Esmolol

object_name: Drug-induced hypotension


subject: CHEBI:8802

subject_name: Remifentanil


subject: CHEMBL.COMPOUND:CHEMBL5314347

subject_name: SEVELAMER CARBONATE

object_name: hyperparathyroidism


subject: CHEMBL.COMPOUND:CHEMBL5314347

object_name: Hyperparathyroidism, CTCAE


subject: UNII:9YCX42I8IU

subject_name: sevelamer carbonate


subject: UNII:9YCX42I8IU


subject: CHEBI:91450

subject_name: Sapanisertib

object_name: Unresectable Solid Neoplasm


subject: CHEBI:91450

object_name: pancreatic neuroendocrine tumor


subject: CHEBI:91450

object_name: Neuroendocrine tumor of pancreas


subject: CHEBI:91450

object_name: fibrolamellar hepatocellular carcinoma


subject: UNII:15C2VL427D

subject_name: Aflibercept


subject: UNII:15C2VL427D

object_name: Recurrent Malignant Solid Neoplasm


subject: UNII:15C2VL427D

object_name: Advanced Malignant Solid Neoplasm


subject: UNII:15C2VL427D


subject: UNII:15C2VL427D


subject: UNII:15C2VL427D

object_name: Refractory Malignant Solid Neoplasm


subject: UNII:15C2VL427D


subject: UNII:15C2VL427D

object_name: ovarian carcinoma


subject: UNII:15C2VL427D

object_name: malignant epithelial tumor of ovary


subject: CHEBI:75275

subject_name: Tetradecyl hydrogen sulfate (ester)

object_name: venous insufficiency


subject: CHEBI:6121

subject_name: Ketamine

object_name: Refractory status epilepticus


subject: CHEBI:6931

subject_name: Midazolam


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin

object_name: Clinical Stage IVA Esophageal Adenocarcinoma AJCC v8


subject: PUBCHEM.COMPOUND:43805

object_name: Pathologic Stage IVA Esophageal Adenocarcinoma AJCC v8


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UMLS:C1314429


subject: CHEBI:75179

subject_name: Trifluridine

object_name: Clinical Stage IIA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:75179

object_name: Pathologic Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:75179

object_name: Clinical Stage IIA Esophageal Adenocarcinoma AJCC v8


subject: CHEBI:75179

object_name: Clinical Stage III Esophageal Adenocarcinoma AJCC v8


subject: CHEBI:75179